New! View global litigation for patent families

CA2103138A1 - Treatment of sleep disorders by nerve stimulation - Google Patents

Treatment of sleep disorders by nerve stimulation

Info

Publication number
CA2103138A1
CA2103138A1 CA 2103138 CA2103138A CA2103138A1 CA 2103138 A1 CA2103138 A1 CA 2103138A1 CA 2103138 CA2103138 CA 2103138 CA 2103138 A CA2103138 A CA 2103138A CA 2103138 A1 CA2103138 A1 CA 2103138A1
Authority
CA
Grant status
Application
Patent type
Prior art keywords
sleep
patient
nerve
signal
eeg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2103138
Other languages
French (fr)
Inventor
Reese S. Terry, Jr.
Joachim F. Wernicke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyberonics Inc
Original Assignee
Reese S. Terry, Jr.
Joachim F. Wernicke
Cyberonics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4806Sleep evaluation
    • A61B5/4818Sleep apnoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04Detecting, measuring or recording bioelectric signals of the body or parts thereof
    • A61B5/0476Electroencephalography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36053Implantable neurostimulators for stimulating central or peripheral nerve system adapted for vagal stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36078Inducing or controlling sleep or relaxation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3601Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36025External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/3611Respiration control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/36128Control systems
    • A61N1/36135Control systems using physiological parameters

Abstract

Method and apparatus (10) for treating and controlling sleep disorders by detecting (37) the presence of the sleep disorder under treatment, and, in response, selectively applying a predetermined generated (12-17, 19, 23) electrical signal to the patient's vagus nerve for stimulation thereof to alleviate the sleep disorder under treatment. The method and apparatus includes several techniques for detecting (37) the presence of the sleep disorder under treatment, such as sensing the patient's EEG activity in the case of insomniac and hypersomnia patients, or detecting a sudden nodding of the head in the case of narcoleptic patients, or sensing the cessation of respiration in the case of sleep apnea patients.

Description

WO92/19318 ' 1 3 ~ 8 PCT/US92/0344, TREATMENT OF SLEEP DISORDERS BY NERVE STIMULATION

Backqround of the Invention The present invention relates generally to methods and apparatus for treating or controlling medical, psychiat-ric or neurological disorders by application of modulating electrical signals to a selected nerve or nerve bundle of the patient, and more particularly to techniques for treating patients with sleep disorders by application of such signals to a cranial nerve, using an implantable neurostimulating device. Specifically, the invention is directed toward treating various sleep disorders, such as insomnia, hypersom-'~ nia, apnea, and narcolepsy, by selective modulation of vagus nerve electrical activity.
Sleep is not a uniform state, but rather involves several stages characterized by changes in the individual's EEG. Stage l sleep is drowsiness, in which the EEG displays a lower voltage, more mixed frequencies and deterioration of ~ alpha rhythm relative to the EEG when the individual is `,~ awake, even when in a relaxed state. In stage 2, background activity similar to that of stage l is experienced, with bursts of slightly higher frequency "sleep spindles" and sporadic higher amplitude slow wave complexes. The third and ~,, fourth stages of sleep display increasing high amplitude slow ' wave activity. A separate sleep stage is one in which the individual undergoes rapid eye movements (REM) with lower voltage, higher frequency EEG and other characteristics s, similar to those which occur when the individual is awake, A whereas the other four sleep stages are categorized as non-REM (NREM) sleep.
Normally, the extent to which NREM stages and REM
~ sleep are experienced, as well as the sleep requirements of i~` the individual, are largely age dependent. Adults typically ~ pass in sequence through the four stages of NREM sleep, and ^~ may enter several spaced periods of REM sleep during the ; 35 night. Adults usually require only six or seven hours of sleep, while infants require sleep during both day and night ~Z
"~ ' ;wos2/ls3lX PCT/US92/0~47 , 1 3 8 ; 2 (normally 50% of the sleep time being spent in REM sleep), and the aged require less sleep than the adult and may experience no REM sleep.
The principal sleep disorders are central sleep apnea, insomnia and hypersomnia, a~d the syndromes thereof.
Other sleep disorders include sleep walking and enuresis ~ (nocturnal incontinence, or bed-wetting). The latter two j disorders are primarily confined to children. Insomnia is a chronic inability to sleep or to remain asleep throughout lo the night, and is usually suffered as a result of various physical and/or physiologic factors, such as pain, discom-fort, anxiety, depression, tension, and obstructive sleep apneas. Sleep apneas are characterized by brief episodes of respiratory arrest, which may occur many times during sleep and may be associated with obstruction of the upper airways, cessation of diaphragmatic movements and snoring. Hypersom-nia is a condition in which the individual undergoes sleep ~ of excessive depth or abnormal duration, usually caused by i physiologic rather than physical factors and characterized by a state of confusion on awakening. Daytime hypersomnia, which may complicate sleep apnea, is commonly represented by the narcoleptic syndrome, characterized by sudden sleep attacks, cataplexy, sleep paralysis, and visual or auditory ' hallucinations at the onset of sleep.
Conventional treatment of insomnia typically involves hypnotics (drugs employed as sedatives), while l treatment of narcolepsy and other syndromes of hypersomnia -~ often utilizes stimulant drugs such as dextro- and laevo-amphetamine and methylphenidate. Unfortunately, however, , 30 treatment with drugs has not proved very effective and often results in undesirable side-effects.
It is a principal o~ject of the present invention - to apply techniques of selective modulation of the electrical activity of a cranial nerve, and particularly the vagus nerve, to treat and control at least the principal sleep disorders, including sleep apnea, insomnia, hypersomnia, narcolepsy, and syndromes thereof.

,~, .
' ,, . '."' .' ~,. .

2 i,J~ 1 3 3 PCTIUS92/03 In addressing a therapy involving nerve stimulation to treat sleep disorders, notice should be taken of existing knowledge that most nerves in the human body are composed of thousands of fibers, having different sizes designated by groups A, B and C, carrying signals to and from the brain and other parts of the body. The vagus nerve, for example, may have approximately l00,000 fibers (axons) of the three different types, each of which carries such signals. Each axon of that nerve only conducts in one direction, in normal circumstances. The A and B fibers are myelinated, that is, they have a myelin sheath in the form of a substance largely composed of fat. On the other hand, the C fibers are unmyelinated.
Myelinated fibers are typically larger, have faster electrical conduction and much lower electrical stimulation ' thresholds than the unmyelinated fibers. Along with the ~, relatively small amounts of electrical energy needed to stimulate the myelinated fibers, it is noteworthy that such fibers exhibit a particular strength-duration curve in response to a specific width and amplitude of stimulation pulse.
The A and B fibers are stimulated with relatively narrow pulse widths, from 50 to 200 microseconds (~), for example. A fibers exhibit slightly faster electrical conduc-tivities than the B fibers, and slightly lower electrical stimulation thresholds. The C fibers are relatively much smaller, conduct electrical signals very 610wly, and have j high stimulation thresholds typically requiring wider pulse widths (e.g., 300-l000 ~) and higher amplitudes for activa-` 30 tion. Although the A and B fibers may be selectively i stimulated without also stimulating the C fibers, the magnitude and width of the pulse required for stimulating the ;~ C fibers would also activate A and B fibers.
Although electrical stimulation of the nerve fiber typically activates neural signals in both directions (bidirectionally), selective unidirectional stimulation is achievable through the use of special nerve electrodes and .
;

:.: , . . , . . . : , . , . . :- , ~ .

W O 92/19318 PC~r/US92/03447 2i~313~ 4 stimulating waveforms. As noted above, each axon of the vagus nerve normally conducts in only one direction.
In a paper on the effects of vagal stimulation on experimentally induced seizures in rats (EDilepsia (1990) 31 (Supp 2): S7-Sl9), Woodbury has noted that the vagus nerve is composed of somatic and visceral afferents (i.e., inward conducting nerve fibers which convey impulses toward a nerve center such as the brain or spinal cord) and efferents (i.e., ; outward conducting nerve fibers which convey impulses to an effector to stimulate it and produce activity). The vast majority of vagal nerve fibers are C fibers, and a majority are visceral afferents having cell bodies lying in masses or ganglia in the neck. The central projections terminate, by ] and large, in the nucleus of the solitary tract which sends fibers to various regions of the brain (e.g, the hypothala-; mus, thalamus, and amygdala); others continue to the medial reticular formation of the medulla, the cerebellum, the nucleus cuneatus and other regions.
WQodbury further notes that stimulation of vagal nerve afferent fibers in animals evokes detectable changes of the EEG in all of these regions, and that the nature and extent of these EEG changes depends on the stimulation parameters. Chase, in Ex Neurol (1966) 16:36-49, had also observed that vagal activation can affect the EEG activity of certain parts of the brain. The applicants herein postulate that synchronization of the EEG may be produced when high frequency (> 70 Hz) weak stimuli activate only the , myelinated (A and B) nerve fibers, and that desynchronization -3 of the EEG occurs when intensity of the stimulus is increased to a level that activates the unmyelinated (C) nerve fibers.
Woodbury also observes that vagal stimulation can produce widespread inhibitory effects on seizures and certain involuntary movements.
'~, Extra-physiologic electrical stimulation of the vagus nerve has previously been proposed for treatment of epilepsy and various forms of involuntary movement disorders.
Specifically, in U.S. Patent 4,702,254 issued October 27, ' ..

W~92/19~18 PCT/US92/03~7 , 2i~138 1987 to J. Zabara (referred to herein as "the '254 patent"), a method and implantable device are disclosed for alleviating or preventing epileptic seizures, characterized by abnormal neural discharge patterns of the brain. The '254 patent describes an implantable neurocybernetic prosthesis (NCP) which utilizes neurocybernetic spectral discrimination by tuning the external current of the NCP generator to the ' electrochemical properties of a specific group of inhibitory nerves that affect the reticular system of the brain. These nerves are embedded within a bundle of other nerves, and are selectively activated directly or indirectly by the tuning of the NCP to augment states of brain neural discharge to control convulsions or seizures. According to the patent, ` the spectr~l discrimination analysis dictates that certain electrical parameters of the NCP pulse generator be selected based on the electrochemical properties of the nerves desired !I' to be activated. The patent further indicates that the optimum sites for application of the NCP generator output to produce the desired effects are the cranial nerves in ;~ 20 general, and the vagus nerve in particular.
The NCP disclosed in the '254 patent may be activated either manually or automatically, to provide treatment for the duration of the seizure. Manual activation ~? iS performed when the patient experiences the aura at onset of the seizure. Alternatively, automatic activation may be triggered upon detection of instantaneous changes in certain ,~ state parameters immediately preceding or at onset of a seizure. Additionally, a prophylactic or preventive mode may be employed in which the NCP is activated periodically to reduce the occurrence and/or the intensity of the seizures.
The NCP stimulator of the '254 patent is implanted in the patient's chest and is connected to electrodes installed at the selected point of signal application at the nerve site with the more negative electrode situated closer to the brain and the positive electrode further from the brain, along the vagus nerv~.

2)~ 6 There is substantial evidence to indicate that sleep is modulated by brain stem centers. Because these centers receive input from the vagus nerve, their activity can be affected by vagal stimulation. The following are some scientific papers of interest on this subject. In Exp. Brain Res. Su~pl. (1984) 8:3-18, Sakai describes synchronized sleep (NREM) and desynchronized sleep (REM) and the brain centers which control them in the cat. Puizillout et al. showed, in Brain Res. (1976) 11:181-184, that vagal stimulation may increase the number or duration of REM episodes, the total amount of REM being found constant; and, in Electroencephal-i oq. Clin. Neurophysiol. (1977) 42:552-563, that sleep cycles may be induced by stimulation of the vagus nerve. Another Puizillout et al. group reviewed, in Ex~. Brain Res. Suppl.
(1984) 8: 20-38, literature on the evidence for involvement of the nucleus of the solitary tract and vagal afferents in ~ modulation of sleep cycles. In Brain Res. Bull. (1985) `! 15:437-441, Juhasz et al. showed that vagal ~Sitimulation directly affects reticular and ventro-posterior-medial nuclei of the cat thalamus; neural activity recorded depended on stimulus parameters, sleep state and site of recording.

Summary of the Invention , The present invention is directed to methods and '$ devices for treating and controlling sleep disorders by 4 25 selective stimulation of the vagus nerve (the tenth cranial nerve) in a predetermined manner to modulate its electrical activity, and thereby synchronize or desynchronize the pa-tient's EEG and/or modify the patient's sleep patterns according to the specific nature of the sleep disorder under treatment. In general, the normal EEG of an awake subject exhibits low voltage and relatively fast activity. Normally i also, the EEG activity slows down during sleep, and displays '$, higher voltage. NREM sleep stage patterns and REM sleep patterns have been discussed briefly in the above background 1 35 section of this document.
.

s s . -WOg2/19318 P~T/US92/03~7 . , 3 1 3 !~
, 7 In the preferred methods of the invention, disor-ders associated with abnormally little sleep (insomnia) are treated by modulating the patient's vagal activity with electrical signal parameters which produce a high voltage synchronous EEG typically seen in the intermediate stages of sleep; whereas disorders associated with abnormally excessive sleep (in terms of suddeness, depth or duration) are treated by modulating the patient's vagal activity with el~ectrical signal parameters or stimuli which desynchronize the patien-t's EEG activity. Both of these categories may employ a ~, sensing (automatic) mode and/or a patient (manual) activation mode for delivery of the therapy.
`l The apparatus of the invention includes a neuro-stimulator (preferably but not necessarily implantable) to selectively apply the desired therapy to treat the sleep i disorder of interest by modulating the electrical activity of the patient's vagus nerve in a predetermined manner. The neurostimulator is programmed by the attending physician to provide the desired therapeutic modality for that purpose.
Selection among various strategies for vagal modulation to treat the sleep disorder depends on a number of factors. These include (i) a consideration of which of the nerve fibers are to be subjected to stimulation; (ii) the modality for achieving synchronization or desynchronization of the EEG; (iii) whether some type of physiologic signal is ,, generated which can be detected and employed to trigger the :J, modulation; and/or (iv) whether a "carryover" or refractory ', period occurs after modulation in which the benefit of the ;'~ modulation is maintained. Although these are not all of the factors to be considered for selecting a stimulation strategy ~ for treatment of the disorder, nor necessarily listed in ;~ order of importance, they are indicative of considerations which may apply in a specific case.
In the treatment according to the invention, different signal parameters and threshold curves are used to activate the various fibers of the patient's vagus nerve for selective modulation of the electrical activity thereof. By .

~`:
WO92/19318 ~i V 31 3 ~ PCT/US92/0~4 i:
; 8 appropriately setting pulse width and amplitude of the electrical signal to be delivered by the neurostimulator to the patient's vagus nerve, the nerve fibers can be selec-tively stimulated, such as A and not B and C; or A and B, but ~ 5 not C; or A, B and C. Various related factors, however, must i be considered in the selection process. For example, because , the C fibers conduct signals very slowly, they are not highly ;;1 responsive to techniques of fast stimulation. Therefore, if ,1 it were desired to increase desynchronous activity of the EEG
by stimulation of the C fibers at 50 Hz, for example, for treatment of narcolepsy in a particular patient, it would be prudent to use a short pulse train for the stimulus. This is because the fibers would become refractory to the stimula-tion within a relatively short time interval and thus incapable of trac~ing the pattern of a longer train. After a suitable recovery period, another short pulse train may be applied to achieve further treatment. The precise pattern to be used, e.g., the length of the time intervals on and , off, will depend upon and be adjusted to the individual s3 20 patient and the particular sleep disorder being treated.
Furthermore, proper designation of amplitude and ~ frequency range of the applied signals allows tuning of the .~3 fibers for EEG synchronization or desynchronization, for 3 control of the disorder. Desynchronization of the EEG has been found to be achieved by stimulation of the vagus nerve at frequencies in the range from 20 to 75 Hz at levels above O.l volt, but requires signals greater than 3 volts at ~3 frequencies above 75 Hz. If the frequency is above 75 Hz and the signal is below 3 volts, EEG synchronization is achieved.
i 30 The actual voltage required depends on the type and geometry of the electrode and the impedance of the electrode-tissue interface.
According to the invention, the basic stimulation strategy is to modulate the electrical activity of the vagus nerve to synchronize or desynchronize the patient's EEG, and, in appropriate cases, to produce the desired patterns of REM
and NREM sleep, depending on the particular sleep disorder ., .
J
, ,~ , , , , ' , . ., ' ' ~ ' ~; , ,.: '' , ' .,~ ' '' , ;" I . ' , i5" ~. . . " ' ' : ': , . .

-; WO92/1931~ 2 1 U 3 1 3 8 PCT/US92/o~, : g and the individual patient. In part, this involves modulat-ing the activity of a number of brain structures, including the limbic system, the hippocampus, and the reticular forma--. tion, the latter being of particular importance in the control of sleep. As described by Rutecki in Epile~sia ` (l990) 31 (Supp. 2): Sl-S6, the vagus nerve projects directly - or indirectly to these brain structures. The strategy may - be implemented by use of a detection sy6tem specific to the sleep disorder of interest, including, if necessary, sense signal analysis circuitry, to trigger automatic stimulatisn of the vagus nerve. Alternatively or additionally, the neurostimulator may be adapted for manual activation by the ; patient upon recognizing onset or continuation of the '~~, disorder (such as inability to sleep, or an overwhelming desire to sleep). For example, for automatic delivery of the stimulus therapy to the narcoleptic patient, surface elec-trodes may be implanted in the head to measure EEG activity, and to activate the neurostimulator to deliver stimuli for desynchronizing the synchronous high voltage slow wave EEG
j 20 activity and increasing the background desynchronous activity ii upon detection of sudden synchronous EEG activity. A more simple, but effective detection strategy for narcolepsy attacks is to implant a miniaturized motion detector to sense ~ a sudden drop of the patient's head. For sleep apnea, the ;1 25 detection may be of the respiratory muscle (chest) movement or of air flow through the nostril (5), to trigger stimulation ~il at onset of an apneic episode.
A stimulation strategy which does not require specific detection involves the use of circadian or other , 30 rhythmic programming to automatically activate vagal stimula-d tion in a manner to induce sleep during the normal nighttime cycle for the insomniac patient, or to arouse and stimulate alertness during the normal daytime cycle for the hypersomn-iac patient. In general, however, a detection strategy appropriate to the disorder of interest is selected to initiate the proper stimulation strategy.

,.

,, W092/1s318 PCT/US92/O~M, ~1 V~)138 lO
Broadly, then, the present invention is directed , to apparatus and methods which employ a neurostimulator device, preferably implantable, for therapy or treatment of sleep disorders through nerve stimulation. The modulating 5signals applied to the vagus nerve may stimulate or inhibit i neural signals to produce excitatory or inhibitory neuro-transmitter release, but for purposes of this disclosure both situations are included within the term "stimulating". It ; should be empha~ized that although the preferred nerve site ~ lOfor application of the modulating signals is the vagus nerve, ': effective treatment may be achieved through application of the stimulus to one or more other nerves, particularly among the cranial nerves, and such treatment is deemed to be within the ambit of the present invention.
15Accordingly, it is another object of the present invention to apply the techniques of selective modulation of vagus nerve electrical activity, using a neurostimulator device which may be implantable, or disposed external to the body with only a small portion of the circuitry implanted or with only the nerve electrode(s) and associated lead(s) implanted percutaneously in the body, to the treatment or control of sleep disorders.
A more specific object of the invention is to ~, provide methods and apparatus responsive to detected symptoms 25characteristic of or associated with certain sleep disorders for applying preprogrammed electrical stimuli to a cranial nerve and particularly the vagus nerve of the patient to modulate the electrical activity of afferent fibers of the ~ nerve as part of a therapy designed to treat or control the 1 30specific disorder, such as by selectively synchronizing or desynchronizing the patient's EEG in the case of the insomni-ac or hypersomniac patient, respectively.
~! Another object of the invention is to provide methods of treating and controlling a sleep disorder by 35sensing a symptom of the disorder and automatically or manually responding thereto by modulating electrical activity of the appropriate brain or brain stem centers through the J

,, .

s ~ . . " -" - ~ . r . . ~ ,, .~' .. ~ WO92/19318 PCT/US92/0~7 ~,1 J~ 1 3 8 application of preselected stimuli to the patient's vagus nerve.

Brief Descri~tion ~ the Drawinas . The above and still further object~, aspects, ~; 5features and attendant advantages of the present invention will be better understood from a consideration of the ensuing .~. detailed description of a presently preferred embodiment and ;' method thereof, taken in conjunction with the accompanying drawings, in which:
- lOFIG. l is a simplified block diagram of an implant-able neurostimulator electronics package (stimulus generator) for use (with appropriate parameter settings and ranges) in ~1 treating sleep disorders according to the present invention;
l FIG. 2 is a simplified fragmentary illustration of ~' 15a preferred embodiment of the stimulus generator and i1 lead/electrode system of the neurostimulator implanted in the patient's body, and of sensor systems suitable for detecting .. certain sleep disorders;
3 FIG. 3 is a detailed fragmentary illustration of i 20the nerve electrode as implanted on the vagal nerve in the 1 neck of the patient for modulating vagal activity;
.3 FIG. 4 is an illustrative idealized electrical output signal waveform of the stimulus generator useful for ~ clarifying relevant parameters of the signal developed by the 3 25stimulus generator for application to the nerve;
~ FIG. 5 is a simplified block diagram of an EE~
.~ spectral analysis circuit which may be used in the stimulus generator in conjunction with an EEG detection system useful for treating insomia and hypersomnia; and ' 30FIG. 6 is another simplified fragmentary illustra-1 tion, similar to that of FIG. 2, but here, of exemplary :. sensor systems suitable for detecting sleep apnea and narcolepsy attacks and which may be worn externally by or ~i~ . implanted in the patient.
,~

"'' ", ~
,. .:, ~

WO92/19318 ~i Jt3l~3 8 PCT/US92/0~7 Descri~tion of the Presentlv Preferred Embodiments and Methods Referring now to the drawings, a block diagram of ' the basic components of the stimulu~ generator of a neurosti-!'~ 5 mulator and their interrelationship is illustrated in FIG.
l, and further details of location of an implantable version of the device and the associated lead/electrode system are shown in FIGS. 2 and 3. A generally suitable form of neurostimulator for use in the apparatus of the present invention is disclosed in copending U.S. patent application Ser. No. 07/434,985, filed November lO, 1989 in the names of , Anthony J. Barrichio, et al. (referred to herein as "the '985 application"), assigned to the same assignee as the instant 3 application. The specification of the '985 application is incorporated herein in its entirety by reference, but certain i portions of it are summarized in this application for the ~1 sake of convenience to the reader.
The neurostimulator utilizes a conventional microprocessor and other standard electrical and electronic components, and in the case of an implanted device, communi-cates with a programmer and/or monitor located external to î the patient s body by asynchronous serial communication for controlling or indicating states of the device. Passwords, j handshakes and parity checks are employed for data integrity.
The neurostimulator also includes means for conserving energy, which is important in any battery operated device and especially so where the device is implanted for medical treatment of a disorder, and means for providing various safety functions such as preventing accidental reset of the device.
The stimulus generator lO (FIG. l~ is preferably adapted to be implantable in the patient's body, in a pocket formed by the surgeon just below the skin in the chest as ' shown in FIG. 2, although a primarily external neurostimula-tor may alternatively be employed. The neurostimulator also includes implantable stimulating electrodes (described below) 1 together with a lead system 22 for applying the output signal .. ~ ' : .

., . ,. , , ~

,. WO 92/lg318 ' ~ PCr/US92/0344 of the stimulus generator to the patient's vagus nerve.
Components external to the patient's body include a program-ming wand for telemetry of parameter changes to the stimulus generator and monitoring signals from the generator, and a computer and associated software for adjustment of parameters and control of communication between the generator, the programming wand and the computer. These external components of the system are not shown in the drawings.
In conjunction with its microprocessor-based logic lo and control circuitry, the stimulus generator 10 or other A~ implanted or external circuitry includes detection circuitry for sensing an event indicative of onset or ongoing presence of the sleep disorder to trigger automatic delivery of the stimulating signal. For example, EEG surface or depth elec-~ 15 trodes may be implanted to sense EEG characteristics associ-;i ated with the particular disorder, eye movement sensors may be implanted to detect REM or NREM sleep, a respiration detector may be implanted in or worn externally by the sleep apnea patient to sense cessation of breathing, or an acceler-ometer may be implanted in the narcoleptic patient to respond to a sudden attack of deep sleep, in each case to trigger the appropriate vagal stimulation therapy programmed into the neurostimulator for the individual patient. Further details of the detection systems will be discussed presently herein.
Use of certain sensors, such as depth EEG electrodes, may involve more delicate electrode/lead implantation procedures and the need for associated analyzing circuitry not required with others, but the use of such sensors can be the most suitable and accurate technique presently achievable for ~'l 30 detecting the serious sleep disorder of interest and initiat-ing appropriate therapy. The stimulus generator is designed, implemented and programmed to deliver a selectively patterned ~ stimulating signal to modulate the electrical activity of the ; vagus nerve in a manner designed to treat and control the disorder.
As shown in FIG. 1, stimulus generator 10 includes a battery (or set of batteries) 12, which may be of any ., , ~,,.;, . , , , ,, . , : , : . , , . . : i:, . : : ~, , . . -:

~ W092/l931~ PCT/US92/0~/
:~ 2i~31~ 14 reliable long-lasting type conventionally employed for ~ powering implantable medical electronic devices (such as i batteries employed in implantable cardiac pacemakers or defibrillators). In the preferred embodiment of the stimulus generator, the battery is a single lithium thionyl chloride cell. The terminals of the cell 12 are connected to the i input side of a voltage regulator 13. The regulator smoothes ~i the battery output to produce a clean, steady output voltage, and provides enhancement thereof such as voltage multiplica-tion or division if necessary for a specific application.
~ Regulator 13 supplies power to logic and control 3 section 15, which includes a microprocessor and controls the programmable functions of the device. Among these program-mable functions are output current or voltage, output signal ' 15 frequency, output signal pulse width, output signal on-time, output signal off-time, daily treatment time for continuous or periodic modulation of vagal activity, and output signal-start delay time. Such programmability allows the output signal to be selectively crafted for application to the ~3 20 stimulating electrode set (FIGS. 2 and 3~ to obtain the desired modulation of vagal activity for treatment and control of the specific sleep disorder. ~iming signals for the logic and control functions of the generator are provided by a crystal oscillator 16. A magnetically-actuated reed switch 14 is incorporated in the electronics package to provide the generator with the capability for patient activation thereof (by use of an external magnet, not shown, ~ placed immediately adjacent to the package or its implant ``~ site).
3 30 Built-in antenna 17 enables communication between , the implanted stimulus generator and the external electronics -, (including both programming and monitoring devices) to permit ~, the device to receive programming signals for parameter changes, and to transmit telemetry information, from and to the programming wand. Once the system is programmed, it operates continuously at the programmed settings until they :~
,:' WO92/19318 PCT/US92/03~7 21~31~8 are reprogrammed (by the attending physician) by means of the external computer and the programming wand.
Logic and control section 15 of the stimulus generator lo controls an output circuit or ~ection 19 which generates the programmed signal levels appropriate to the ~; disorder being treated. The output 6ection and its pro-grammed output signal are coupled (directly, capacitively, or inductively) to an electrical connector 20 on the housing 21 of the generator and to lead assembly 22 connected to the ; lo stimulating electrodes (FIGS. 2 and 3). A sense signal analysis circuit 23 is provided within the generator housing ~; 21, with connections to the microprocessor in logic and control section 15 and to the sensing electrodes. An exemplary sense signal analysis circuit for use with implant-ed EEG sensing electrodes to cause the microprocessor to , trigger delivery of therapy by the output circuit of the generator on detection of a selected event, is shown in FIG.

5 and will be described presently. The parameters of the stimulating signal of the implanted device may be calibrated by telemetry (via the programming wand) according to the needs of the particular patient and the results then pro-grammed into the microprocessor for delivery of the appro-priate treatment upon activation of the stimulaus generator.
~ Housing 21 in which stimulus generator 10 is ;~ 25 encased is hermetically sealed and composed of a material such as titanium which is biologically compatible with the fluids and tissue of the patient's body. Further details of suitable structure and operation of the neurostimulator, ~ beyond those by which the device is adapted to treat the ! 30 disorder as described herein, are available in the '985 application, to which the reader is referred.
~ FIG. 2 illustrates the preferred location of i implanted generator 10, in case 21 with connector 20, in the ~, patient's chest in a cavity formed by the implanting surgeon just below the skin, much as a pacemaker pulse generator ~, would be implanted. A stimulating nerve electrode set 25 (FIG. 3) is conductively connected to the distal end of ,.

~ wos2~ls31~ PCT/US92/0344/
21 ,, t,1 3~

insulated electrically conductive lead assembly 22 which is attached at its proximal end to connector 20. Electrode set 25 is a bipolar stimulating electrode, preferably of the type described in U.S. Patent 4,573,481 issued March 4, 1986 to ~ 5 Bullara. The electrode assembly is surgically implanted on`~ the vagus nerve 27 in the patient's neck. The two electrodes 25-1 and 25-2 are wrapped about the vagus nerve, and the assembly is secured to the nerve by a spiral anchoring tether 28 preferably as disclosed in U.S. Patent 4,979,511 issued December 25, 1990 to Reese S. Terry, Jr. and assigned to the same assignee as the instant application. ~ead(s) 22 is secured, while retaining the ability to flex with movement ' of the chest and neck, by a suture connection 30 to nearby tissue.
The open helical design of electrode assembly 25 (described in detail in the above-cited sullara patent), which is self-sizing and flexible, minimizes mechanical trauma to the nerve and allows body fluid interchange with the nerve. The electrode assembly conforms to the shape of `~ 20 the nerve, providing a low stimulation threshold by allowing a larger stimulation contact area. Structurally, the electrode assembly comprises two ribbons of platinum consti-tuting the electrodes which are individually bonded to the inside surface of each of the first two spiral loops 25-1 and : 25 25-2 of a three-loop helical assembly, and the two lead wires are respectively welded to the conductive ribbon electrodes.
3 The remainder of each loop is composed of silicone rubber,and the third loop acts as the tether 28 for the electrode assembly. The inner diameter of the helical bipolar elec-trode assembly may typically be approximately two millimeters (mm), and an individual spiral is about seven mm long (measured along the axis of the nerve).
For purposes of detecting the EEG characteristics associated with insomnia or hypersomnia sleep disorder, depth ¦ 35 EEG sense electrodes 36 may be implanted in spaced apart relation through the skull, and connected to leads 37 implanted via a catheter or other suitable means (not shown) ,'' .

WO92/19318 PCT/~S92/03~7 ~1 ~,3~
; 17 and extending along the scalp and temple and then along the jawline through the neck and chest tissue to the sense signal analysis circuit 23 of stimulus generator lo. Alternatively, or additionally, if prescribed by the attending physician, 5 eye movement sensing electrodes 33 may be implanted at or ; near the outer periphery of each eye socket in a suitable location to sense muscle movement, or actual eye movement by ~ placement about the nerves which control such movement, as - shown in FIG. 2. The sense electrodes 33 are utilized to detect REM and NREM sleep, and are electrically connected to leads 34 implanted and extending toward the ears and then generally along the same path and in the same manner as described above for the EEG sense electrode leads. In this `~ case, the signal analysis circuit would be simplified, ~ 15 consisting for example of a logic circuit which generates an ~ activation command to the microprocessor upon detecting a j predetermined count within a set period of time, indicative ~ of REM sleep.
- For sleep apnea patients, the cessation of respira-tion is detected, in a preferred embodiment, by an external-~ ly-positioned breathing sensor placed in the patient's `i nostril as shown at 50 in FIG. 6. A suitable breathing sensor merely detects the presence or absence of nasal air ; flow and is worn in or near one nostril, only at night or . 25 anytime that the patient retires to sleep, such as at nap j times for infant or elderly patients. Processing of the nasal air flow signal is performed by a suitable external ~' circuit 53 which is adapted to generate an activation command to the microprocessor of logic and control circuit 15. A
suitable processing circuit is an external RF signal genera-`; tor positioned in the vicinity of the implanted stimulus generator 10 and triggered by a sustained absence of nasal air flow for a predetermined interval of time. The selected time interval should be sufficiently long to reasonably ass~ure that the patient has stopped breathing momentarily, and yet sufficiently short to allow the detection to be made , ,' ~

;~ WO92/1931X PCT/US92/0~7 21~,138 18 and the vagal stimulation to be commenced before the pa-` tient's sleep i6 interrupted.
Although external devices are less attractive than implants to most patients, in this instance the cosmetic considerations are less significant because the external devices are worn or used by the sleep apnea patient only at times when the intention or expectation is to sleep.
However, a totally implanted respiration detection system may be employed, if desired, for example using a device which senses movement of the patient's diaphragm associated with normal breathing. Preferably, the diaphragm movement is sensed by an impedance detector, or alternatively, by plural 3 electrodes for detecting physical movement of the muscle, implanted in the chest of the patient as shown generally at 60 in FIG. 6. The detector generates a signal indicative of absence of diaphram movement for a time interval set accord-ing to the above-mentioned criteria, which is conveyed by -~ implanted lead 62 to trigger application of vagal stimulation by generator lO under the command of the microprocessor.
For the narcoleptic patient, a miniaturized accelerometer in the form of a movement detecting electronic or electromechanical switch, for example, may be implanted beneath the skin as generally shown at 65 in FIG. 6. The ~i accelerometer position is selected to respond to sudden nodding or dropping of the patient's head, which results from the brief attack of deep sleep characteristic of narcolepsy, 7 to generate a signal on implanted lead 67 to trigger stimula-1 tion of the vagus nerve.
The stimulus generator may be programmed with an IBM-compatible personal computer (not shown) using program-ming software of the type copyrighted by the assignee of the instant application with the Register of Copyrights, Library ~ of Congress, or other suitable software based on the descrip-s tion herein, and a programming wand (not shown). The wand ;
, 35 and software permit noninvasive communication with the generator after the latter is implanted. The wand is preferably powered by internal batteries, and provided with ,', WO92/19318 PCT/US92/0~47 ' 19 2 la3l~s a "power on" light to indicate sufficient power for communi-cation. Another indicator light is preferably provided to show that data transmission is occurring between the wand and the generator.
The operation of stimulus generator lO to control and treat sleep disorders will be described with reference to FIG. 4, which illustrates the general nature, in idealized representation, of the output signal waveform delivered by , output section l9 of the neurostimulator to electrode ~ lO assembly 25. This illustration is presented principally for ;~ the sake of clarifying terminology, including the parameters ^, of output signal on-time, output signal off-time, output ~ signal frequency, output signal pulse width, and output j signal current or voltage.
~ 15 In the treatment of sleep disorders according to ;~ the invention, the stimulation strategy is to program the neurostimulator to synchronize the patient's EEG activity in the case of insomniac patients, and to desynchronize the EEG
~A, activ-ity in the case of hypersomniac, narcoleptic or sleep apnea patients. For synchronization, the parameters of the stimulus signal may be programmed, for example, at a frequen- i cy of 90 Hz, an output current of l.0 mA, and a pulse width of O.lO ms for the pulse waveform. For desynchronization, i the corresponding parameters of an exemplary pulse waveform would be 20 Hz, 1.5 mA, and 0.5 ms. A patient suffering from insomnia may simply activate the neurostimulator when he or ~ she is unable to sleep. This may be accomplished in a number -~! of different ways, one example being to place an external ;~ magnet directly over the site of the implanted stimulus generator to actuate the reed switch 14 (FIG. l).
1 A suitable range of stimulation parameters for synchronization or desynchronization of the patient's EEG
; activity, as appropriate, and the typical value of each parameter of the stimulating output signal for treatment of the disorder are as follows:
,`1, . .

:. :

~,~:,, , , - - . :

WO92/19318 PCT/~S92/03 2i~l3 8 20 Desynch, Synch, Ranqe Tv~ical Tv~ical Pulse Width 0.05 - l.5 ms 0.5 ms 0.l ms output Current 0.l - 5.0 mA 1.5 mA l.0 mA
, 5 Frequency 5 - 150 Hz 20 Hz so Hz 3 ON Time 5 - 5000 sec 300 sec 30 sec OFF Time 5 - 5000 sec 20 sec 30 sec Frequency sweep l0 - l00 Hz Optional Random frequency l0 - l00 Hz Optional As noted earlier herein, a technique for initiating stimulation without a specific detection system requires that the neurostimulator be programmed according to the circadian rhythm of the particular patient and the disorder being , treated, to either desynchronize or synchronize the patient's EEG activity as appropriate.
, .j A signal analysis circuit 23 for stimulus generator l0 (FIG. l), suitable for processing the EEG waveform developed by surface or depth EEG electrodes, is shown in greater detail in FIG. 5. In this exemplary embodiment, the sensing electrodes are EEG electrodes such as 36 and associ-ated leads 37 of FIG. 2, and the analysis circuit 23 is .~ .
implemented for EEG detection and analysis. To that end, ~, circuit 23 includes a plurality of parallel active sense signal bandpass filters 40 staged to provide selective filtering in the ranges from 0-2 Hz, 2-4 Hz and 15-20 Hz, for ~ example; a logic circuit 42 to select the output of one -~ filter from among the plurality of filters 40; and an analog/digital (A/D) converter 45. The outputs of the filteFs are individually sampled by the logic circuit 42, and ,, .
-~3 ~WO92/1g318 PCT/US92/03~7 ~1~3138 the sampling rate, averaging time interval, and weighting assigned to each sense signal band are controlled by the microprocessor in the logic and control section 15 of the stimulus generator lO (FIG. l), to detect the EEG pattern.
When the selected event is detected, the processed digital signal is supplied to the microprocessor to trigger applica-,~ tion of the stimulating signal to the patient's vagus nerve.
' As specified above, other types of signal process-ing circuits may be used depending on the specific type of '`7 10 detection required, or, in some instances, the output of the ~ sensing device itself may be used directly without further .:
~ processing.
;~ Various features may be incorporated into the neurostimulator for purposes of the safety and comfort of the patient. For example, comfort would be enhanced by program-ming the output 6timulus to ramp up during the first two ~ seconds of stimulation, rather than to be delivered abruptly.
-~ Also, the implanted generator may be provided with a clamping circuit to limit the maximum voltage, to 14 volts for example, which is delivered to the vagus nerve. Such a ¦ maximum limit is designed to prevent injury to the patient's ;, vagus nerve.
~ Thè programmable functions and capabilities of the -~ neurostimulator are designed and implemented to permit noninvasive communication with the stimulus generator after it is implanted, which is useful for both activation and ~ monitoring functions. Beyond the essential functions of the -- device, the programming software may readily be structured . 1~

,i , '.~
,' ~ .

` WO92/19318 PCT/US92/03447 2i~3~

to prcvide straightforward menu-driven operation, HELP func-tions, prompts, and messages to facilitate simple and rapid programming while keeping the user fully informed of every-thing occurring at each step of a sequence. Programming ~ 5 capabilities should include capability to modify the adjust-- able parameters of the stimulus generator and its output signal, to test device diagnostic~, and to store and retrieve telemetered data. It is desirable that when the implanted unit is interrogated, the present state of the adjustable parameters is displayed on the monitor of external PC so that the programmer may then conveniently change any or all of those parameters at the same time; and, if a particular ~ parameter is selected for change, all permissible values for j that parameter are displayed so that the programmer may select an appropriate desired value for entry into the neurostimulator.
Diagnostics testing should be implemented to verify .
proper operation of the device, and to indicate the existence of problems such as with communication, the battery, or the lead/electrode impedance. A low battery reading, for example, would be indicative of imminent end of life of the battery and need for implantation of a new device. The nerve electrodes are capable of indefinite use absent indication of a problem with them observed on the diagnostics testing.
Although a preferred embodiment and methods of treating and controlling sleep disorders according to the invention have been described herein, it will be apparent to those skilled in the field from a consideration of the . . .

; wos2/1s31x PCT/US92/0~7 ` 23 21~313~
- foregoing description that variation~ and modifications of such embodiments, methods and techniques may be made without departing from the true spirit and scope of the invention.
For example, although a totally implantable neurostimulator , 5 device is preferred (with the possible exception of the detection system), the electronic energization package may, if desired, be primarily external to the body. Stimulation ~, can be achieved with an RF power device implemented to provide the necessary energy level. The implanted components may be limited to the lead/electrode assembly, a coil and a DC rectifier. Pulses programmed with the desired parameters would be transmitted through the skin with an RF carrier, and the signal thereafter rectified to regenerate a pulsed siqnal for application as the stimulus to the vagus nerve to modulate vagal activity. This would virtually eliminate the need for battery changes. The disadvantages of such an implementation are that the external transmitter must be carried by the patient, greater power is required for activation, and the output current to the nerve is less -3 20 stable.
~ An external stimulus generator may be employed with .
leads extending percutaneously to the implanted nerve electrode set. The major problem encountered with this technique is the potential for infection, but it is useful ` 25 to allow short term testing of the patient to determine whether the sleep disorder suffered by the patient under ~ observation is amenable to successful treatment. If it is, 1, a more permanent implant may be provided.

~ .

.~ .

:

,,, - ,, . , ., ,.. ... .. ',. , . ,,,, ... .... ,., ' , ' . .,, .,.: :.,: ,, .. !,: ,. . , .' '., .: . ' ., -WO92/19318 PCT/US92/0~7 h ~ V ~1 1 3 ~

Accordingly, it is intended that the invention shall be limited only to the extent required by the appended ~j claims and the rules and principles of applicable law.

J

.1 .
,J
,~
.. ~
. .

.~1 ' :1 "
^ ~ .

.$

~'`'.'i ' .

,-,''.1 .
.'j , .

~1 .
.~
:s ., , .:

Claims (24)

1. A method of treating patients with sleep disor-ders, which includes detecting an event indicative of the sleep disorder to be treated, and upon detection of said event, selectively applying a predetermined electrical signal to the patient's vagus nerve for stimulation thereof to alleviate the sleep disorder under treatment.
2. The method of claim 1, wherein the predetermined electrical signal is programmable to modulate the electrical activity of the vagus nerve to control the EEG activity of the patient.
3. The method of claim 2, wherein the predetermined electrical signal is a pulse waveform with signal parameters programmable to synchronize or desynchronize the patient's EEG activity according to the nature of the sleep disorder under treatment.
4. The method of claim 3, wherein the detected event is one of (i) a desynchronous EEG pattern indicative of inability of the patient to sleep during nighttime hours, and (ii) a synchronous EEG pattern indicative of overwhelming desire of the patient to sleep during daytime hours; and the pulse waveform is programmed to synchronize the patient's EEG activity upon detected event (i), and to desynchronize the patient's EEG activity upon detected event (ii).
5. The method of claim 1, wherein the detected event includes one of (i) an EEG
pattern of the patient reflecting presence of the sleep disorder under treatment, (ii) a sudden uncontrolled nodding of the patient's head, and (iii) a cessation of respiration by the patient.
6. The method of claim 5, wherein the predetermined signal has electrical parameters programmed to stimulate the vagus nerve to cause desynchron-ization of the patient's EEG upon detected event (ii).
7. The method of claim 5, wherein the predetermined signal has electrical parameters programmed to stimulate the vagus nerve to cause desynchron-ization of the patient's EEG upon detected event (iii).
8. The method of claim 1, wherein the event is detectable by the patient, and the electrical signal is manually activatable.
9. The method of claim 3, wherein the programmable signal parameters of the pulse waveform include at least some of pulse width, output current or voltage, frequency, on time and off time.
10. The method of claim 3, wherein the disorder under treatment is insomnia, and the pulse waveform signal parameters are programmed to synchronize the activity of the patient's EEG.
11. The method of claim 3, wherein the disorder under treatment is hypersomnia, and the pulse waveform signal parameters are programmed to desynchronize the activity of the patient's EEG.
12. A method of treating patients with sleep disorder, which includes detecting the presence of the sleep disorder under treatment, and, in response thereto, selec-tively applying a programmed electrical signal to a selected cranial nerve of the patient to modulate the electrical activity of the selected cranial nerve in a predetermined manner to alleviate the sleep disorder under treatment.
13. The method of claim 12, wherein said electrical signal is a pulse waveform with programmable signal parameters, and is applied to a nerve electrode implanted on the patient's vagus nerve.
14. The method of claim 13, wherein the programmable parameter values of the pulse waveform include pulse width, output current, frequency, on time and off time.
15. In a method of treating patients with sleep disorders, the step of applying an electrical signal with parameters programmed to alleviate the sleep disorder under treatment to the vagus nerve of the patient to modulate the electrical activity thereof at predetermined times and for predetermined time intervals during the patient's circadian cycle.
16. A device for treating sleep disorders in human patients, comprising:
stimulus means for generating a programmable electrical waveform, implantable electrode means electrically connect-able to said stimulus means for delivering said waveform to the vagus nerve of the patient, and programming means for applying said waveform to said electrode means with selected parameter values of the waveform programmed to stimulate the vagus nerve to modulate the electrical activity thereof and thereby controllably vary the patient's EEG activity according to the nature of the sleep disorder under treatment.
17. The invention of claim 16, wherein said programming means includes means for selecting the parameter values of the waveform to synchronize or desynchronize the activity of the patient's EEG according to whether the sleep disorder under treatment is insomnia-related or hypersomnia-related, respectively.
18. The invention of claim 16, further including sensing means to detect an event indicative of the presence of the sleep disorder under treatment, for initiat-ing the application of said waveform to said electrode means.
19. The invention of claim 16, wherein said programming means applies said waveform to said electrode means at predetermined times and for predeter-mined time intervals during the patient's circadian cycle.
20. The invention of claim 18, wherein said sensing means includes means for detecting the EEG activity of the patient.
21. The invention of claim 18, wherein said sensing means includes means for detecting a cessation of respiration of the patient.
22. The invention of claim 21, wherein said means for detecting cessation of respiration includes means responsive to the absence of movement of the patient's diaphragm.
23. The invention of claim 21, wherein said means for detecting cessation of respiration includes means responsive to the absence of nasal air flow by the patient.
24. The invention of claim 18, wherein said sensing means includes means for detecting a sudden uncontrolled nodding of the patient's head.
CA 2103138 1991-05-03 1992-05-01 Treatment of sleep disorders by nerve stimulation Abandoned CA2103138A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US07695558 US5335657A (en) 1991-05-03 1991-05-03 Therapeutic treatment of sleep disorder by nerve stimulation
US695,558 1991-05-03

Publications (1)

Publication Number Publication Date
CA2103138A1 true true CA2103138A1 (en) 1992-11-04

Family

ID=24793505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2103138 Abandoned CA2103138A1 (en) 1991-05-03 1992-05-01 Treatment of sleep disorders by nerve stimulation

Country Status (4)

Country Link
US (1) US5335657A (en)
EP (1) EP0584211A4 (en)
CA (1) CA2103138A1 (en)
WO (1) WO1992019318A1 (en)

Families Citing this family (511)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600916A4 (en) * 1991-07-22 1995-11-02 Cyberonics Inc Treatment of respiratory disorders by nerve stimulation.
DE4142427A1 (en) * 1991-12-20 1993-06-24 Hans Dipl Ing Dokoupil Medical device to diagnose and treatment of sleep disorders
US5897579A (en) * 1994-09-15 1999-04-27 Mount Sinai School Of Medicine Method of relieving airway obstruction in patients with bilateral vocal impairment
US5540731A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for pressure detecting and treating obstructive airway disorders
US5546952A (en) * 1994-09-21 1996-08-20 Medtronic, Inc. Method and apparatus for detection of a respiratory waveform
US5522862A (en) * 1994-09-21 1996-06-04 Medtronic, Inc. Method and apparatus for treating obstructive sleep apnea
US5485851A (en) * 1994-09-21 1996-01-23 Medtronic, Inc. Method and apparatus for arousal detection
US5549655A (en) * 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US5540733A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for detecting and treating obstructive sleep apnea
US5540732A (en) * 1994-09-21 1996-07-30 Medtronic, Inc. Method and apparatus for impedance detecting and treating obstructive airway disorders
US5483969A (en) * 1994-09-21 1996-01-16 Medtronic, Inc. Method and apparatus for providing a respiratory effort waveform for the treatment of obstructive sleep apnea
US5540734A (en) * 1994-09-28 1996-07-30 Zabara; Jacob Cranial nerve stimulation treatments using neurocybernetic prosthesis
US20020169485A1 (en) 1995-10-16 2002-11-14 Neuropace, Inc. Differential neurostimulation therapy driven by physiological context
US5591216A (en) * 1995-05-19 1997-01-07 Medtronic, Inc. Method for treatment of sleep apnea by electrical stimulation
GB9511964D0 (en) * 1995-06-13 1995-08-09 Rdm Consultants Limited Monitoring an EEG
US5620467A (en) * 1995-10-10 1997-04-15 Incontrol, Inc. Implantable atrial defibrillator having cardioverting output voltage limiting for simulating larger storage capacitors
US5690681A (en) * 1996-03-29 1997-11-25 Purdue Research Foundation Method and apparatus using vagal stimulation for control of ventricular rate during atrial fibrillation
US5683422A (en) * 1996-04-25 1997-11-04 Medtronic, Inc. Method and apparatus for treating neurodegenerative disorders by electrical brain stimulation
US8036741B2 (en) * 1996-04-30 2011-10-11 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US5711316A (en) * 1996-04-30 1998-01-27 Medtronic, Inc. Method of treating movement disorders by brain infusion
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US7269457B2 (en) 1996-04-30 2007-09-11 Medtronic, Inc. Method and system for vagal nerve stimulation with multi-site cardiac pacing
US6021352A (en) * 1996-06-26 2000-02-01 Medtronic, Inc, Diagnostic testing methods and apparatus for implantable therapy devices
US6093158A (en) 1997-05-15 2000-07-25 Morris; Donald E. Systems for modifying behavioral disorders
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6479523B1 (en) 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
WO1999020339A1 (en) * 1997-10-17 1999-04-29 Respironics, Inc. Muscle stimulating device and method for diagnosing and treating a breathing disorder
US6016449A (en) * 1997-10-27 2000-01-18 Neuropace, Inc. System for treatment of neurological disorders
US6647296B2 (en) * 1997-10-27 2003-11-11 Neuropace, Inc. Implantable apparatus for treating neurological disorders
GB9802382D0 (en) * 1998-02-04 1998-04-01 Medtronic Inc Apparatus for management of sleep apnea
US6269269B1 (en) 1998-04-23 2001-07-31 Medtronic Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US6251126B1 (en) 1998-04-23 2001-06-26 Medtronic Inc Method and apparatus for synchronized treatment of obstructive sleep apnea
US9415222B2 (en) 1998-08-05 2016-08-16 Cyberonics, Inc. Monitoring an epilepsy disease state with a supervisory module
US8762065B2 (en) 1998-08-05 2014-06-24 Cyberonics, Inc. Closed-loop feedback-driven neuromodulation
US7231254B2 (en) 1998-08-05 2007-06-12 Bioneuronics Corporation Closed-loop feedback-driven neuromodulation
US7277758B2 (en) 1998-08-05 2007-10-02 Neurovista Corporation Methods and systems for predicting future symptomatology in a patient suffering from a neurological or psychiatric disorder
US9375573B2 (en) 1998-08-05 2016-06-28 Cyberonics, Inc. Systems and methods for monitoring a patient's neurological disease state
US7974696B1 (en) 1998-08-05 2011-07-05 Dilorenzo Biomedical, Llc Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US7403820B2 (en) 1998-08-05 2008-07-22 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7209787B2 (en) 1998-08-05 2007-04-24 Bioneuronics Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US9042988B2 (en) 1998-08-05 2015-05-26 Cyberonics, Inc. Closed-loop vagus nerve stimulation
US7747325B2 (en) 1998-08-05 2010-06-29 Neurovista Corporation Systems and methods for monitoring a patient's neurological disease state
US7242984B2 (en) 1998-08-05 2007-07-10 Neurovista Corporation Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US7324851B1 (en) 1998-08-05 2008-01-29 Neurovista Corporation Closed-loop feedback-driven neuromodulation
US7853329B2 (en) 1998-08-05 2010-12-14 Neurovista Corporation Monitoring efficacy of neural modulation therapy
JP2000163196A (en) * 1998-09-25 2000-06-16 Sanyo Electric Co Ltd Gesture recognizing device and instruction recognizing device having gesture recognizing function
US6748275B2 (en) * 1999-05-05 2004-06-08 Respironics, Inc. Vestibular stimulation system and method
EP1198271A4 (en) 1999-06-25 2009-01-21 Univ Emory Devices and methods for vagus nerve stimulation
US6308102B1 (en) 1999-09-29 2001-10-23 Stimsoft, Inc. Patient interactive neurostimulation system and method
US6654642B2 (en) 1999-09-29 2003-11-25 Medtronic, Inc. Patient interactive neurostimulation system and method
US6473639B1 (en) 2000-03-02 2002-10-29 Neuropace, Inc. Neurological event detection procedure using processed display channel based algorithms and devices incorporating these procedures
US6944501B1 (en) 2000-04-05 2005-09-13 Neurospace, Inc. Neurostimulator involving stimulation strategies and process for using it
US6466822B1 (en) 2000-04-05 2002-10-15 Neuropace, Inc. Multimodal neurostimulator and process of using it
US7120489B2 (en) 2000-05-08 2006-10-10 Brainsgate, Ltd. Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the BBB and cerebral blood flow
US7640062B2 (en) 2000-05-08 2009-12-29 Brainsgate Ltd. Methods and systems for management of alzheimer's disease
US8010189B2 (en) * 2004-02-20 2011-08-30 Brainsgate Ltd. SPG stimulation for treating complications of subarachnoid hemorrhage
US7117033B2 (en) * 2000-05-08 2006-10-03 Brainsgate, Ltd. Stimulation for acute conditions
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
US9233245B2 (en) 2004-02-20 2016-01-12 Brainsgate Ltd. SPG stimulation
US7561919B2 (en) * 2002-11-14 2009-07-14 Brainsgate Ltd. SPG stimulation via the greater palatine canal
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US6512955B1 (en) 2000-08-07 2003-01-28 Mcenany Thomas J. Electrical apparatus for therapeutic treatment
US6591138B1 (en) 2000-08-31 2003-07-08 Neuropace, Inc. Low frequency neurostimulator for the treatment of neurological disorders
US6487446B1 (en) * 2000-09-26 2002-11-26 Medtronic, Inc. Method and system for spinal cord stimulation prior to and during a medical procedure
US8086314B1 (en) 2000-09-27 2011-12-27 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US7499742B2 (en) 2001-09-26 2009-03-03 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US7623926B2 (en) 2000-09-27 2009-11-24 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7840271B2 (en) 2000-09-27 2010-11-23 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7616997B2 (en) 2000-09-27 2009-11-10 Kieval Robert S Devices and methods for cardiovascular reflex control via coupled electrodes
US20070173893A1 (en) * 2000-10-20 2007-07-26 Pitts Walter C Method and apparatus for preventing obstructive sleep apnea
US6529774B1 (en) 2000-11-09 2003-03-04 Neuropace, Inc. Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation
US20050251061A1 (en) * 2000-11-20 2005-11-10 Schuler Eleanor L Method and system to record, store and transmit waveform signals to regulate body organ function
US6597953B2 (en) * 2001-02-20 2003-07-22 Neuropace, Inc. Furcated sensing and stimulation lead
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
WO2002073526A3 (en) * 2001-03-13 2002-12-12 Wide Horizon Holdings Inc Cerebral programming
US6892098B2 (en) * 2001-04-26 2005-05-10 Biocontrol Medical Ltd. Nerve stimulation for treating spasticity, tremor, muscle weakness, and other motor disorders
US6641542B2 (en) * 2001-04-30 2003-11-04 Medtronic, Inc. Method and apparatus to detect and treat sleep respiratory events
US7151914B2 (en) * 2001-08-21 2006-12-19 Medtronic, Inc. Transmitter system for wireless communication with implanted devices
US8204591B2 (en) 2002-05-23 2012-06-19 Bio Control Medical (B.C.M.) Ltd. Techniques for prevention of atrial fibrillation
US7734355B2 (en) 2001-08-31 2010-06-08 Bio Control Medical (B.C.M.) Ltd. Treatment of disorders by unidirectional nerve stimulation
US6684105B2 (en) 2001-08-31 2004-01-27 Biocontrol Medical, Ltd. Treatment of disorders by unidirectional nerve stimulation
US8060197B2 (en) * 2003-05-23 2011-11-15 Bio Control Medical (B.C.M.) Ltd. Parasympathetic stimulation for termination of non-sinus atrial tachycardia
US8571653B2 (en) 2001-08-31 2013-10-29 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
US6907295B2 (en) 2001-08-31 2005-06-14 Biocontrol Medical Ltd. Electrode assembly for nerve control
US7974693B2 (en) 2001-08-31 2011-07-05 Bio Control Medical (B.C.M.) Ltd. Techniques for applying, configuring, and coordinating nerve fiber stimulation
US7885709B2 (en) 2001-08-31 2011-02-08 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation for treating disorders
US7844346B2 (en) * 2002-05-23 2010-11-30 Biocontrol Medical Ltd. Electrode assembly for nerve control
US7778711B2 (en) * 2001-08-31 2010-08-17 Bio Control Medical (B.C.M.) Ltd. Reduction of heart rate variability by parasympathetic stimulation
US7778703B2 (en) * 2001-08-31 2010-08-17 Bio Control Medical (B.C.M.) Ltd. Selective nerve fiber stimulation for treating heart conditions
US6668195B2 (en) 2001-10-30 2003-12-23 Medtronic, Inc. Methods and apparatus for reducing the likelihood of atrial fibrillation
US8612005B2 (en) * 2002-02-01 2013-12-17 The Cleveland Clinic Foundation Neurostimulation for affecting sleep disorders
EP1476220A4 (en) * 2002-02-01 2009-12-16 Cleveland Clinic Foundation Delivery device for stimulating the sympathetic nerve chain
US7110820B2 (en) 2002-02-05 2006-09-19 Tcheng Thomas K Responsive electrical stimulation for movement disorders
US20090259279A1 (en) * 2002-03-22 2009-10-15 Dobak Iii John D Splanchnic nerve stimulation for treatment of obesity
US7239912B2 (en) * 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US7937145B2 (en) * 2002-03-22 2011-05-03 Advanced Neuromodulation Systems, Inc. Dynamic nerve stimulation employing frequency modulation
US7702386B2 (en) * 2002-03-22 2010-04-20 Leptos Biomedical, Inc. Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes
US7551964B2 (en) * 2002-03-22 2009-06-23 Leptos Biomedical, Inc. Splanchnic nerve stimulation for treatment of obesity
US7689277B2 (en) * 2002-03-22 2010-03-30 Leptos Biomedical, Inc. Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US7236822B2 (en) * 2002-03-22 2007-06-26 Leptos Biomedical, Inc. Wireless electric modulation of sympathetic nervous system
US7689276B2 (en) * 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20060206150A1 (en) 2002-04-08 2006-09-14 Ardian, Inc. Methods and apparatus for treating acute myocardial infarction
US8131371B2 (en) 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8145317B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US9308043B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US20030195571A1 (en) * 2002-04-12 2003-10-16 Burnes John E. Method and apparatus for the treatment of central sleep apnea using biventricular pacing
US7684859B2 (en) 2002-04-25 2010-03-23 Brainsgate Ltd. Stimulation of the OTIC ganglion for treating medical conditions
US20080077192A1 (en) * 2002-05-03 2008-03-27 Afferent Corporation System and method for neuro-stimulation
US20030216789A1 (en) * 2002-05-14 2003-11-20 The Foundry, Inc. Method and system for treating sleep apnea
JP2004121837A (en) * 2002-09-11 2004-04-22 Sanyo Electric Co Ltd Movable bed
US8579786B2 (en) * 2002-10-15 2013-11-12 Medtronic, Inc. Screening techniques for management of a nervous system disorder
US8187181B2 (en) * 2002-10-15 2012-05-29 Medtronic, Inc. Scoring of sensed neurological signals for use with a medical device system
WO2004034885A3 (en) * 2002-10-15 2004-07-01 Medtronic Inc Signal quality monitoring and control for a medical device system
US20040153436A1 (en) * 2002-10-15 2004-08-05 Pope Cameron A. Automated information management system and methods
US7149572B2 (en) * 2002-10-15 2006-12-12 Medtronic, Inc. Phase shifting of neurological signals in a medical device system
EP1578487B1 (en) * 2002-10-15 2012-01-25 Medtronic, Inc. Channel-selective blanking for a medical device system
US20040138518A1 (en) * 2002-10-15 2004-07-15 Medtronic, Inc. Medical device system with relaying module for treatment of nervous system disorders
EP1558330A4 (en) * 2002-10-15 2008-10-01 Medtronic Inc Cycle mode providing redundant back-up to ensure termination of treatment therapy in a medical device system
US8594798B2 (en) * 2002-10-15 2013-11-26 Medtronic, Inc. Multi-modal operation of a medical device system
EP1562674A4 (en) * 2002-10-15 2008-10-08 Medtronic Inc Control of treatment therapy during start-up and during operation of a medical device system
EP1565102A4 (en) * 2002-10-15 2008-05-28 Medtronic Inc Synchronization and calibration of clocks for a medical device and calibrated clock
US7933646B2 (en) 2002-10-15 2011-04-26 Medtronic, Inc. Clustering of recorded patient neurological activity to determine length of a neurological event
WO2004036377A3 (en) * 2002-10-15 2004-07-29 Naresh C Bhavaraju Configuring and testing treatment therapy parameters for a medical device system
WO2004034880A3 (en) * 2002-10-15 2004-07-22 Medtronic Inc Timed delay for redelivery of treatment therapy for a medical device system
WO2004044947A3 (en) * 2002-11-14 2005-07-07 Brainsgate Ltd Stimulation circuitry and control of electronic medical device
US7636597B2 (en) 2002-11-14 2009-12-22 Brainsgate, Ltd. Surgical tools and techniques for stimulation
US7252640B2 (en) * 2002-12-04 2007-08-07 Cardiac Pacemakers, Inc. Detection of disordered breathing
US7189204B2 (en) 2002-12-04 2007-03-13 Cardiac Pacemakers, Inc. Sleep detection using an adjustable threshold
US7025730B2 (en) * 2003-01-10 2006-04-11 Medtronic, Inc. System and method for automatically monitoring and delivering therapy for sleep-related disordered breathing
US8064994B2 (en) * 2003-01-14 2011-11-22 The United States Of America As Represented By The Department Of Veterans Affairs Cervical vagal stimulation induced weight loss
US20040172084A1 (en) 2003-02-03 2004-09-02 Knudson Mark B. Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)
US20050070974A1 (en) * 2003-09-29 2005-03-31 Knudson Mark B. Obesity and eating disorder stimulation treatment with neural block
US7444183B2 (en) * 2003-02-03 2008-10-28 Enteromedics, Inc. Intraluminal electrode apparatus and method
US7613515B2 (en) * 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
US7844338B2 (en) 2003-02-03 2010-11-30 Enteromedics Inc. High frequency obesity treatment
DE60308555T2 (en) * 2003-02-21 2007-09-13 Medtronic, Inc., Minneapolis Programming an implantable neurostimulators with indication of the service life of the battery
US7092755B2 (en) * 2003-03-18 2006-08-15 Pacesetter, Inc. System and method of cardiac pacing during sleep apnea
US7499750B2 (en) 2003-04-11 2009-03-03 Cardiac Pacemakers, Inc. Noise canceling cardiac electrodes
US7155278B2 (en) * 2003-04-21 2006-12-26 Medtronic, Inc. Neurostimulation to treat effects of sleep apnea
US20060111755A1 (en) * 2003-05-16 2006-05-25 Stone Robert T Method and system to control respiration by means of neuro-electrical coded signals
US20050261747A1 (en) * 2003-05-16 2005-11-24 Schuler Eleanor L Method and system to control respiration by means of neuro-electrical coded signals
US20060064137A1 (en) * 2003-05-16 2006-03-23 Stone Robert T Method and system to control respiration by means of simulated action potential signals
US7477932B2 (en) 2003-05-28 2009-01-13 Cardiac Pacemakers, Inc. Cardiac waveform template creation, maintenance and use
US7149574B2 (en) * 2003-06-09 2006-12-12 Palo Alto Investors Treatment of conditions through electrical modulation of the autonomic nervous system
US7738952B2 (en) * 2003-06-09 2010-06-15 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system
US7321793B2 (en) 2003-06-13 2008-01-22 Biocontrol Medical Ltd. Vagal stimulation for atrial fibrillation therapy
EP1648560A4 (en) 2003-06-13 2015-10-28 Biocontrol Medical Ltd Vagal stimulation for anti-embolic therapy
US7720541B2 (en) * 2003-08-18 2010-05-18 Cardiac Pacemakers, Inc. Adaptive therapy for disordered breathing
US7680537B2 (en) * 2003-08-18 2010-03-16 Cardiac Pacemakers, Inc. Therapy triggered by prediction of disordered breathing
EP2008581B1 (en) 2003-08-18 2011-08-17 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US7396333B2 (en) 2003-08-18 2008-07-08 Cardiac Pacemakers, Inc. Prediction of disordered breathing
US8396565B2 (en) 2003-09-15 2013-03-12 Medtronic, Inc. Automatic therapy adjustments
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US7664546B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Posture detection system and method
US7668591B2 (en) 2003-09-18 2010-02-23 Cardiac Pacemakers, Inc. Automatic activation of medical processes
US7510531B2 (en) 2003-09-18 2009-03-31 Cardiac Pacemakers, Inc. System and method for discrimination of central and obstructive disordered breathing events
US8251061B2 (en) 2003-09-18 2012-08-28 Cardiac Pacemakers, Inc. Methods and systems for control of gas therapy
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US20050142070A1 (en) * 2003-09-18 2005-06-30 Hartley Jesse W. Methods and systems for assessing pulmonary disease with drug therapy control
US7757690B2 (en) * 2003-09-18 2010-07-20 Cardiac Pacemakers, Inc. System and method for moderating a therapy delivered during sleep using physiologic data acquired during non-sleep
US7336996B2 (en) * 2003-09-18 2008-02-26 Cardiac Pacemakers, Inc. Rate regularization of cardiac pacing for disordered breathing therapy
US20050080348A1 (en) 2003-09-18 2005-04-14 Stahmann Jeffrey E. Medical event logbook system and method
US7302295B2 (en) 2003-09-18 2007-11-27 Cardiac Pacemakers, Inc. Method and apparatus for mimicking respiratory sinus arrhythmia with cardiac pacing controlled via external respiration therapy device
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
US7678061B2 (en) * 2003-09-18 2010-03-16 Cardiac Pacemakers, Inc. System and method for characterizing patient respiration
US7610094B2 (en) 2003-09-18 2009-10-27 Cardiac Pacemakers, Inc. Synergistic use of medical devices for detecting medical disorders
US7572225B2 (en) * 2003-09-18 2009-08-11 Cardiac Pacemakers, Inc. Sleep logbook
US7591265B2 (en) 2003-09-18 2009-09-22 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7575553B2 (en) 2003-09-18 2009-08-18 Cardiac Pacemakers, Inc. Methods and systems for assessing pulmonary disease
US20050070972A1 (en) * 2003-09-26 2005-03-31 Wahlstrand Carl D. Energy shunt for producing an MRI-safe implantable medical device
US20050153885A1 (en) * 2003-10-08 2005-07-14 Yun Anthony J. Treatment of conditions through modulation of the autonomic nervous system
US7480532B2 (en) 2003-10-22 2009-01-20 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US7396331B2 (en) * 2003-10-27 2008-07-08 Home Guardian, Llc System and process for non-invasive collection and analysis of physiological signals
US20060069415A1 (en) * 2003-11-20 2006-03-30 Advanced Neuromodulation Systems, Inc. Electrical stimulation system, lead, and method providing modified reduced neuroplasticity effect
WO2005051480A3 (en) * 2003-11-20 2006-06-15 Advanced Neuromodulation Sys Electrical stimulation system, lead, and method providing reduced neuroplasticity effects
US9050469B1 (en) 2003-11-26 2015-06-09 Flint Hills Scientific, Llc Method and system for logging quantitative seizure information and assessing efficacy of therapy using cardiac signals
US20060241718A1 (en) * 2003-11-26 2006-10-26 Wicab, Inc. Systems and methods for altering brain and body functions and for treating conditions and diseases of the same
US20090312817A1 (en) * 2003-11-26 2009-12-17 Wicab, Inc. Systems and methods for altering brain and body functions and for treating conditions and diseases of the same
CA2547445C (en) * 2003-11-26 2009-03-10 Wicab, Inc. Systems and methods for altering vestibular biology
US7319900B2 (en) 2003-12-11 2008-01-15 Cardiac Pacemakers, Inc. Cardiac response classification using multiple classification windows
US7774064B2 (en) 2003-12-12 2010-08-10 Cardiac Pacemakers, Inc. Cardiac response classification using retriggerable classification windows
US8521284B2 (en) 2003-12-12 2013-08-27 Cardiac Pacemakers, Inc. Cardiac response classification using multisite sensing and pacing
US20090198293A1 (en) * 2003-12-19 2009-08-06 Lawrence Cauller Microtransponder Array for Implant
US20050137652A1 (en) * 2003-12-19 2005-06-23 The Board of Regents of the University of Texas at Dallas System and method for interfacing cellular matter with a machine
US20050149132A1 (en) 2003-12-24 2005-07-07 Imad Libbus Automatic baroreflex modulation based on cardiac activity
US7706884B2 (en) * 2003-12-24 2010-04-27 Cardiac Pacemakers, Inc. Baroreflex stimulation synchronized to circadian rhythm
US20050143378A1 (en) 2003-12-29 2005-06-30 Yun Anthony J. Treatment of conditions through pharmacological modulation of the autonomic nervous system
US7676269B2 (en) * 2003-12-29 2010-03-09 Palo Alto Investors Treatment of female fertility conditions through modulation of the autonomic nervous system
US7792583B2 (en) 2004-03-16 2010-09-07 Medtronic, Inc. Collecting posture information to evaluate therapy
US7717848B2 (en) * 2004-03-16 2010-05-18 Medtronic, Inc. Collecting sleep quality information via a medical device
US8725244B2 (en) * 2004-03-16 2014-05-13 Medtronic, Inc. Determination of sleep quality for neurological disorders
US7491181B2 (en) * 2004-03-16 2009-02-17 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US7330760B2 (en) * 2004-03-16 2008-02-12 Medtronic, Inc. Collecting posture information to evaluate therapy
US8308661B2 (en) * 2004-03-16 2012-11-13 Medtronic, Inc. Collecting activity and sleep quality information via a medical device
US7881798B2 (en) 2004-03-16 2011-02-01 Medtronic Inc. Controlling therapy based on sleep quality
US7366572B2 (en) * 2004-03-16 2008-04-29 Medtronic, Inc. Controlling therapy based on sleep quality
US8055348B2 (en) * 2004-03-16 2011-11-08 Medtronic, Inc. Detecting sleep to evaluate therapy
US7395113B2 (en) * 2004-03-16 2008-07-01 Medtronic, Inc. Collecting activity information to evaluate therapy
US20070276439A1 (en) * 2004-03-16 2007-11-29 Medtronic, Inc. Collecting sleep quality information via a medical device
US7542803B2 (en) * 2004-03-16 2009-06-02 Medtronic, Inc. Sensitivity analysis for selecting therapy parameter sets
US7805196B2 (en) * 2004-03-16 2010-09-28 Medtronic, Inc. Collecting activity information to evaluate therapy
US20050209512A1 (en) * 2004-03-16 2005-09-22 Heruth Kenneth T Detecting sleep
WO2005087313A1 (en) * 2004-03-18 2005-09-22 David Peter Shaw Method and apparatus for the treatment of sleep apnoea and snoring
US8729129B2 (en) 2004-03-25 2014-05-20 The Feinstein Institute For Medical Research Neural tourniquet
US7551599B2 (en) * 2004-03-29 2009-06-23 Corrigent Systems Ltd. Layer-3 network routing with RPR layer-2 visibility
US9155877B2 (en) 2004-03-30 2015-10-13 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US8989840B2 (en) * 2004-03-30 2015-03-24 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7877150B2 (en) 2004-03-30 2011-01-25 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7174219B2 (en) * 2004-03-30 2007-02-06 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7844344B2 (en) 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable lead
US7844343B2 (en) * 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable medical device
US8135473B2 (en) * 2004-04-14 2012-03-13 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US7313440B2 (en) * 2004-04-14 2007-12-25 Medtronic, Inc. Collecting posture and activity information to evaluate therapy
US9220917B2 (en) 2006-04-12 2015-12-29 The Invention Science Fund I, Llc Systems for autofluorescent imaging and target ablation
US8353896B2 (en) 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US8000784B2 (en) * 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling device
US9011329B2 (en) 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
US8361013B2 (en) 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US9801527B2 (en) 2004-04-19 2017-10-31 Gearbox, Llc Lumen-traveling biological interface device
US7850676B2 (en) 2004-04-19 2010-12-14 The Invention Science Fund I, Llc System with a reservoir for perfusion management
US7998060B2 (en) 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US8337482B2 (en) 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US20120035540A1 (en) 2006-04-12 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Event-based control of a lumen traveling device
US8019413B2 (en) 2007-03-19 2011-09-13 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US7899527B2 (en) * 2004-05-13 2011-03-01 Palo Alto Investors Treatment of conditions through modulation of the autonomic nervous system during at least one predetermined menstrual cycle phase
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
JP5175092B2 (en) 2004-06-01 2013-04-03 クワラタ トレーディング リミティド invitro techniques using stem cells
US7596413B2 (en) * 2004-06-08 2009-09-29 Cardiac Pacemakers, Inc. Coordinated therapy for disordered breathing including baroreflex modulation
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US20060025828A1 (en) * 2004-07-28 2006-02-02 Armstrong Randolph K Impedance measurement for an implantable device
US8569277B2 (en) * 2004-08-11 2013-10-29 Palo Alto Investors Methods of treating a subject for a condition
US7623924B2 (en) * 2004-08-31 2009-11-24 Leptos Biomedical, Inc. Devices and methods for gynecologic hormone modulation in mammals
US8092549B2 (en) 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US7340302B1 (en) 2004-09-27 2008-03-04 Pacesetter, Inc. Treating sleep apnea in patients using phrenic nerve stimulation
US7734340B2 (en) * 2004-10-21 2010-06-08 Advanced Neuromodulation Systems, Inc. Stimulation design for neuromodulation
WO2006047264A1 (en) * 2004-10-21 2006-05-04 Advanced Neuromodulation Systems, Inc. Peripheral nerve stimulation to treat auditory dysfunction
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US7627384B2 (en) 2004-11-15 2009-12-01 Bio Control Medical (B.C.M.) Ltd. Techniques for nerve stimulation
US7974223B2 (en) * 2004-11-19 2011-07-05 Corrigent Systems Ltd. Virtual private LAN service over ring networks
US20060110374A1 (en) * 2004-11-24 2006-05-25 Dudy Czeiger Method to accelerate stem cell recruitment and homing
US7561922B2 (en) * 2004-12-22 2009-07-14 Biocontrol Medical Ltd. Construction of electrode assembly for nerve control
US8609082B2 (en) 2005-01-25 2013-12-17 Bio Control Medical Ltd. Administering bone marrow progenitor cells or myoblasts followed by application of an electrical current for cardiac repair, increasing blood supply or enhancing angiogenesis
US8565867B2 (en) 2005-01-28 2013-10-22 Cyberonics, Inc. Changeable electrode polarity stimulation by an implantable medical device
US9314633B2 (en) 2008-01-25 2016-04-19 Cyberonics, Inc. Contingent cardio-protection for epilepsy patients
US8280526B2 (en) 2005-02-01 2012-10-02 Medtronic, Inc. Extensible implantable medical lead
US20060212097A1 (en) * 2005-02-24 2006-09-21 Vijay Varadan Method and device for treatment of medical conditions and monitoring physical movements
US7680534B2 (en) 2005-02-28 2010-03-16 Cardiac Pacemakers, Inc. Implantable cardiac device with dyspnea measurement
US8700163B2 (en) 2005-03-04 2014-04-15 Cyberonics, Inc. Cranial nerve stimulation for treatment of substance addiction
US7519431B2 (en) 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US7392086B2 (en) 2005-04-26 2008-06-24 Cardiac Pacemakers, Inc. Implantable cardiac device and method for reduced phrenic nerve stimulation
US20060247693A1 (en) 2005-04-28 2006-11-02 Yanting Dong Non-captured intrinsic discrimination in cardiac pacing response classification
US8027736B2 (en) * 2005-04-29 2011-09-27 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7853332B2 (en) * 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7974202B2 (en) 2005-05-06 2011-07-05 Corrigent Systems, Ltd. Tunnel provisioning with link aggregation
US7644714B2 (en) 2005-05-27 2010-01-12 Apnex Medical, Inc. Devices and methods for treating sleep disorders
WO2006130268A1 (en) * 2005-06-01 2006-12-07 Medtronic, Inc. Correlating a non-polysomnographic physiological parameter set with sleep states
US7840280B2 (en) 2005-07-27 2010-11-23 Cyberonics, Inc. Cranial nerve stimulation to treat a vocal cord disorder
US7706874B2 (en) 2005-07-28 2010-04-27 Cyberonics, Inc. Stimulating cranial nerve to treat disorders associated with the thyroid gland
US8660647B2 (en) 2005-07-28 2014-02-25 Cyberonics, Inc. Stimulating cranial nerve to treat pulmonary disorder
US7856273B2 (en) 2005-07-28 2010-12-21 Cyberonics, Inc. Autonomic nerve stimulation to treat a gastrointestinal disorder
US7672727B2 (en) 2005-08-17 2010-03-02 Enteromedics Inc. Neural electrode treatment
US7822486B2 (en) * 2005-08-17 2010-10-26 Enteromedics Inc. Custom sized neural electrodes
US8055347B2 (en) 2005-08-19 2011-11-08 Brainsgate Ltd. Stimulation for treating brain events and other conditions
US9050005B2 (en) 2005-08-25 2015-06-09 Synapse Biomedical, Inc. Method and apparatus for transgastric neurostimulation
US20070073354A1 (en) 2005-09-26 2007-03-29 Knudson Mark B Neural blocking therapy
US7860566B2 (en) * 2005-10-06 2010-12-28 The Cleveland Clinic Foundation System and method for achieving regular slow ventricular rhythm in response to atrial fibrillation
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US7555344B2 (en) * 2005-10-28 2009-06-30 Cyberonics, Inc. Selective neurostimulation for treating epilepsy
US8016776B2 (en) * 2005-12-02 2011-09-13 Medtronic, Inc. Wearable ambulatory data recorder
US8725243B2 (en) 2005-12-28 2014-05-13 Cyberonics, Inc. Methods and systems for recommending an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
US8868172B2 (en) 2005-12-28 2014-10-21 Cyberonics, Inc. Methods and systems for recommending an appropriate action to a patient for managing epilepsy and other neurological disorders
US7672728B2 (en) * 2005-12-28 2010-03-02 Cardiac Pacemakers, Inc. Neural stimulator to treat sleep disordered breathing
US20070156200A1 (en) * 2005-12-29 2007-07-05 Lilian Kornet System and method for regulating blood pressure and electrolyte balance
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US7983150B2 (en) * 2006-01-18 2011-07-19 Corrigent Systems Ltd. VPLS failure protection in ring networks
US7974697B2 (en) * 2006-01-26 2011-07-05 Cyberonics, Inc. Medical imaging feedback for an implantable medical device
US7657310B2 (en) 2006-01-26 2010-02-02 Cyberonics, Inc. Treatment of reproductive endocrine disorders by vagus nerve stimulation
US7769455B2 (en) * 2006-01-27 2010-08-03 Cyberonics, Inc. Power supply monitoring for an implantable device
US7801601B2 (en) * 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
US7808931B2 (en) * 2006-03-02 2010-10-05 Corrigent Systems Ltd. High capacity ring communication network
WO2007102162A3 (en) 2006-03-08 2009-04-23 Kwalata Trading Ltd Regulating stem cells
US8744587B2 (en) * 2006-03-24 2014-06-03 Medtronic, Inc. Collecting gait information for evaluation and control of therapy
US8615309B2 (en) 2006-03-29 2013-12-24 Catholic Healthcare West Microburst electrical stimulation of cranial nerves for the treatment of medical conditions
US7545740B2 (en) * 2006-04-07 2009-06-09 Corrigent Systems Ltd. Two-way link aggregation
US8180462B2 (en) 2006-04-18 2012-05-15 Cyberonics, Inc. Heat dissipation for a lead assembly
US8326431B2 (en) * 2006-04-28 2012-12-04 Medtronic, Inc. Implantable medical device for the concurrent treatment of a plurality of neurological disorders and method therefore
US7348805B2 (en) * 2006-05-02 2008-03-25 International Business Machines Corporation Chip-to-chip digital transmission circuit delivering power over signal lines
US7593400B2 (en) * 2006-05-19 2009-09-22 Corrigent Systems Ltd. MAC address learning in a distributed bridge
US8295926B2 (en) 2006-06-02 2012-10-23 Advanced Neuromodulation Systems, Inc. Dynamic nerve stimulation in combination with other eating disorder treatment modalities
WO2007150003A3 (en) 2006-06-23 2008-11-06 Neurovista Corp Minimally invasive monitoring systems and methods
US8478420B2 (en) 2006-07-12 2013-07-02 Cyberonics, Inc. Implantable medical device charge balance assessment
US20080027524A1 (en) 2006-07-26 2008-01-31 Maschino Steven E Multi-electrode assembly for an implantable medical device
US7660303B2 (en) 2006-08-22 2010-02-09 Corrigent Systems Ltd. Point-to-multipoint functionality in a bridged network
US8121692B2 (en) 2006-08-30 2012-02-21 Cardiac Pacemakers, Inc. Method and apparatus for neural stimulation with respiratory feedback
US8050765B2 (en) * 2006-08-30 2011-11-01 Cardiac Pacemakers, Inc. Method and apparatus for controlling neural stimulation during disordered breathing
US7904176B2 (en) 2006-09-07 2011-03-08 Bio Control Medical (B.C.M.) Ltd. Techniques for reducing pain associated with nerve stimulation
US8209013B2 (en) 2006-09-14 2012-06-26 Cardiac Pacemakers, Inc. Therapeutic electrical stimulation that avoids undesirable activation
JP5327542B2 (en) * 2006-09-28 2013-10-30 ウイスコンシン アラムナイ リサーチ ファウンデーシヨンWisconsin Alumni Research Foundation How to promote restorative sleep and equipment
US7797046B2 (en) 2006-10-11 2010-09-14 Cardiac Pacemakers, Inc. Percutaneous neurostimulator for modulating cardiovascular function
US7797041B2 (en) * 2006-10-11 2010-09-14 Cardiac Pacemakers, Inc. Transcutaneous neurostimulator for modulating cardiovascular function
US9186511B2 (en) 2006-10-13 2015-11-17 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
EP2478931B1 (en) 2006-10-13 2015-12-30 Cyberonics, Inc. Obstructive sleep apnea treatment device
US20090306741A1 (en) * 2006-10-26 2009-12-10 Wicab, Inc. Systems and methods for altering brain and body functions and for treating conditions and diseases of the same
US8295934B2 (en) 2006-11-14 2012-10-23 Neurovista Corporation Systems and methods of reducing artifact in neurological stimulation systems
EP2121124A1 (en) 2006-12-15 2009-11-25 Nasophlex B.V. Resuscitation device and method for resuscitation
US7697525B2 (en) * 2006-12-21 2010-04-13 Corrigent Systems Ltd. Forwarding multicast traffic over link aggregation ports
WO2008092133A3 (en) 2007-01-25 2008-09-12 Neurovista Corp Methods and systems for measuring a subject's susceptibility to a seizure
US9898656B2 (en) 2007-01-25 2018-02-20 Cyberonics, Inc. Systems and methods for identifying a contra-ictal condition in a subject
US7706875B2 (en) 2007-01-25 2010-04-27 Cyberonics, Inc. Modulation of drug effects by vagus nerve stimulation
US7974707B2 (en) 2007-01-26 2011-07-05 Cyberonics, Inc. Electrode assembly with fibers for a medical device
WO2008098001A3 (en) 2007-02-05 2008-10-09 Synapse Biomedical Inc Removable intramuscular electrode
US9044593B2 (en) 2007-02-14 2015-06-02 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US8036736B2 (en) 2007-03-21 2011-10-11 Neuro Vista Corporation Implantable systems and methods for identifying a contra-ictal condition in a subject
US8364273B2 (en) * 2007-04-24 2013-01-29 Dirk De Ridder Combination of tonic and burst stimulations to treat neurological disorders
US8483842B2 (en) 2007-04-25 2013-07-09 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US7869884B2 (en) * 2007-04-26 2011-01-11 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7904175B2 (en) * 2007-04-26 2011-03-08 Cyberonics, Inc. Trans-esophageal vagus nerve stimulation
US7962214B2 (en) * 2007-04-26 2011-06-14 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US20080318314A1 (en) * 2007-06-20 2008-12-25 Valentin Fulga Production from blood of cells of neural lineage
US7630771B2 (en) * 2007-06-25 2009-12-08 Microtransponder, Inc. Grooved electrode and wireless microtransponder system
US7818069B2 (en) * 2007-07-27 2010-10-19 Cyberonics, Inc. Ribbon electrode
US9788744B2 (en) 2007-07-27 2017-10-17 Cyberonics, Inc. Systems for monitoring brain activity and patient advisory device
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US20090118777A1 (en) * 2007-08-09 2009-05-07 Kobi Iki Efferent and afferent splanchnic nerve stimulation
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
EP2207590A1 (en) * 2007-09-26 2010-07-21 Medtronic, INC. Therapy program selection
US8380314B2 (en) 2007-09-26 2013-02-19 Medtronic, Inc. Patient directed therapy control
US20090264789A1 (en) * 2007-09-26 2009-10-22 Medtronic, Inc. Therapy program selection
WO2009051638A1 (en) 2007-10-16 2009-04-23 Medtronic, Inc. Therapy control based on a patient movement state
US7860569B2 (en) 2007-10-18 2010-12-28 Brainsgate, Ltd. Long-term SPG stimulation therapy for prevention of vascular dementia
US8868203B2 (en) * 2007-10-26 2014-10-21 Cyberonics, Inc. Dynamic lead condition detection for an implantable medical device
US8942798B2 (en) * 2007-10-26 2015-01-27 Cyberonics, Inc. Alternative operation mode for an implantable medical device based upon lead condition
US8428726B2 (en) * 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
US20090204173A1 (en) 2007-11-05 2009-08-13 Zi-Ping Fang Multi-Frequency Neural Treatments and Associated Systems and Methods
US8457757B2 (en) 2007-11-26 2013-06-04 Micro Transponder, Inc. Implantable transponder systems and methods
DE112008003180T5 (en) * 2007-11-26 2011-03-03 Micro-Transponder, Inc., Dallas Implantable transponder systems and procedures
US8160695B2 (en) 2007-12-05 2012-04-17 The Invention Science Fund I, Llc System for chemical modulation of neural activity
US8165669B2 (en) 2007-12-05 2012-04-24 The Invention Science Fund I, Llc System for magnetic modulation of neural conduction
US8195287B2 (en) 2007-12-05 2012-06-05 The Invention Science Fund I, Llc Method for electrical modulation of neural conduction
US8170660B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for thermal modulation of neural activity
US8165668B2 (en) 2007-12-05 2012-04-24 The Invention Science Fund I, Llc Method for magnetic modulation of neural conduction
US8180446B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method and system for cyclical neural modulation based on activity state
US8180447B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method for reversible chemical modulation of neural activity
US8170658B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for electrical modulation of neural conduction
US9259591B2 (en) 2007-12-28 2016-02-16 Cyberonics, Inc. Housing for an implantable medical device
US8260426B2 (en) * 2008-01-25 2012-09-04 Cyberonics, Inc. Method, apparatus and system for bipolar charge utilization during stimulation by an implantable medical device
WO2009094050A1 (en) 2008-01-25 2009-07-30 Medtronic, Inc. Sleep stage detection
EP2890449B1 (en) 2012-08-31 2017-04-05 Flint Hills Scientific, LLC Contingent cardio-protection for epilepsy patients
EP2254661B1 (en) 2008-02-14 2015-10-07 Cardiac Pacemakers, Inc. Apparatus for phrenic stimulation detection
US9037263B2 (en) 2008-03-12 2015-05-19 Medtronic, Inc. System and method for implantable medical device lead shielding
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211409B2 (en) 2008-03-31 2015-12-15 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US8204603B2 (en) * 2008-04-25 2012-06-19 Cyberonics, Inc. Blocking exogenous action potentials by an implantable medical device
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
JP2011523566A (en) 2008-05-02 2011-08-18 ダイメディックス コーポレイション Agitator in order to stimulate the central nervous system
NL2001694C2 (en) * 2008-06-18 2009-12-22 Nasophlex B V Ear stimulator for producing a stimulation signal to an ear.
NL2001697C2 (en) 2008-06-18 2009-12-22 Nasophlex B V Nose stimulator for producing a stimulation signal to a nose.
NL2001698C2 (en) 2008-06-18 2009-12-22 Nasophlex B V Cardioverter / defibrillator.
US9089707B2 (en) * 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
US8231556B2 (en) 2008-07-11 2012-07-31 Medtronic, Inc. Obtaining baseline patient information
US9440084B2 (en) 2008-07-11 2016-09-13 Medtronic, Inc. Programming posture responsive therapy
US20100010577A1 (en) 2008-07-11 2010-01-14 Medtronic, Inc. Linking posture states for posture responsive therapy
US8504150B2 (en) 2008-07-11 2013-08-06 Medtronic, Inc. Associating therapy adjustments with posture states using a stability timer
US8708934B2 (en) 2008-07-11 2014-04-29 Medtronic, Inc. Reorientation of patient posture states for posture-responsive therapy
US8200340B2 (en) 2008-07-11 2012-06-12 Medtronic, Inc. Guided programming for posture-state responsive therapy
US9327129B2 (en) 2008-07-11 2016-05-03 Medtronic, Inc. Blended posture state classification and therapy delivery
US8447411B2 (en) 2008-07-11 2013-05-21 Medtronic, Inc. Patient interaction with posture-responsive therapy
US9050471B2 (en) 2008-07-11 2015-06-09 Medtronic, Inc. Posture state display on medical device user interface
WO2010011969A1 (en) 2008-07-24 2010-01-28 Boston Scientific Neuromodulation Corporation System and method for avoiding, reversing, and managing neurological accomodation to electrical stimulation
US20100056941A1 (en) * 2008-08-22 2010-03-04 Dymedix Corporation Device controller and datalogger for a closed loop neuromodulator
US20100069772A1 (en) * 2008-09-12 2010-03-18 Dymedix Corporation Wireless pyro/piezo sensor transceiver
US8280517B2 (en) 2008-09-19 2012-10-02 Medtronic, Inc. Automatic validation techniques for validating operation of medical devices
US8936556B2 (en) * 2008-09-24 2015-01-20 Cardiac Pacemakers, Inc. Minute ventilation-based disordered breathing detection
US8457747B2 (en) * 2008-10-20 2013-06-04 Cyberonics, Inc. Neurostimulation with signal duration determined by a cardiac cycle
US8417344B2 (en) 2008-10-24 2013-04-09 Cyberonics, Inc. Dynamic cranial nerve stimulation based on brain state determination from cardiac data
EP2355893B1 (en) 2008-11-18 2013-12-25 Setpoint Medical Corporation Devices for optimizing electrode placement for anti-inflamatory stimulation
JP5575789B2 (en) * 2008-11-19 2014-08-20 インスパイア・メディカル・システムズ・インコーポレイテッドInspire Medical Systems, Inc. A method of treatment of sleep-disordered breathing
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8849390B2 (en) 2008-12-29 2014-09-30 Cyberonics, Inc. Processing for multi-channel signals
US9744354B2 (en) 2008-12-31 2017-08-29 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8588933B2 (en) 2009-01-09 2013-11-19 Cyberonics, Inc. Medical lead termination sleeve for implantable medical devices
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
US20100268297A1 (en) * 2009-02-24 2010-10-21 Hans Neisz Duodenal Stimulation To Induce Satiety
US8321030B2 (en) 2009-04-20 2012-11-27 Advanced Neuromodulation Systems, Inc. Esophageal activity modulated obesity therapy
EP3228350A1 (en) 2009-04-22 2017-10-11 Nevro Corporation Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US8827912B2 (en) 2009-04-24 2014-09-09 Cyberonics, Inc. Methods and systems for detecting epileptic events using NNXX, optionally with nonlinear analysis parameters
US8239028B2 (en) 2009-04-24 2012-08-07 Cyberonics, Inc. Use of cardiac parameters in methods and systems for treating a chronic medical condition
US8172759B2 (en) * 2009-04-24 2012-05-08 Cyberonics, Inc. Methods and systems for detecting epileptic events using nonlinear analysis parameters
US8175720B2 (en) 2009-04-30 2012-05-08 Medtronic, Inc. Posture-responsive therapy control based on patient input
US20120035696A1 (en) 2009-04-30 2012-02-09 Medtronic, Inc. Termination of a shield within an implantable medical lead
US9327070B2 (en) 2009-04-30 2016-05-03 Medtronic, Inc. Medical device therapy based on posture and timing
US9026223B2 (en) 2009-04-30 2015-05-05 Medtronic, Inc. Therapy system including multiple posture sensors
US8340772B2 (en) 2009-05-08 2012-12-25 Advanced Neuromodulation Systems, Inc. Brown adipose tissue utilization through neuromodulation
US8786624B2 (en) 2009-06-02 2014-07-22 Cyberonics, Inc. Processing for multi-channel signals
CN102573986B (en) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 Nerve cuff having a pocket portion for a leadless stimulator
US8267851B1 (en) * 2009-06-16 2012-09-18 James M Kroll Method and apparatus for electrically generating signal for inducing lucid dreaming
US8224449B2 (en) * 2009-06-29 2012-07-17 Boston Scientific Neuromodulation Corporation Microstimulator with flap electrodes
US9697336B2 (en) 2009-07-28 2017-07-04 Gearbox, Llc Electronically initiating an administration of a neuromodulation treatment regimen chosen in response to contactlessly acquired information
US8498710B2 (en) 2009-07-28 2013-07-30 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
US8942817B2 (en) * 2009-07-28 2015-01-27 The Invention Science Fund I, Llc Broadcasting a signal indicative of a disease, disorder, or symptom determined in response to contactlessly acquired information
US8374701B2 (en) * 2009-07-28 2013-02-12 The Invention Science Fund I, Llc Stimulating a nervous system component of a mammal in response to contactlessly acquired information
US8346354B2 (en) * 2009-07-28 2013-01-01 The Invention Science Fund I, Llc Determining a neuromodulation treatment regimen in response to contactlessly acquired information
US20110093032A1 (en) * 2009-08-05 2011-04-21 Ndi Medical, Llc Systems and methods for maintaining airway patency
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9770204B2 (en) * 2009-11-11 2017-09-26 Medtronic, Inc. Deep brain stimulation for sleep and movement disorders
WO2011079309A3 (en) 2009-12-23 2011-11-24 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
US9149210B2 (en) 2010-01-08 2015-10-06 Medtronic, Inc. Automated calibration of posture state classification for a medical device
US8579834B2 (en) 2010-01-08 2013-11-12 Medtronic, Inc. Display of detected patient posture state
US9357949B2 (en) 2010-01-08 2016-06-07 Medtronic, Inc. User interface that displays medical therapy and posture data
US9643019B2 (en) 2010-02-12 2017-05-09 Cyberonics, Inc. Neurological monitoring and alerts
JP2013523274A (en) 2010-03-30 2013-06-17 ザ チルドレンズ リサーチ インスティテュート Apparatus and method for measuring human pain
US20110251468A1 (en) 2010-04-07 2011-10-13 Ivan Osorio Responsiveness testing of a patient having brain state changes
US8478428B2 (en) 2010-04-23 2013-07-02 Cyberonics, Inc. Helical electrode for nerve stimulation
US8874229B2 (en) 2010-04-28 2014-10-28 Cyberonics, Inc. Delivering scheduled and unscheduled therapy without detriment to battery life or accuracy of longevity predictions
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8562536B2 (en) 2010-04-29 2013-10-22 Flint Hills Scientific, Llc Algorithm for detecting a seizure from cardiac data
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8423134B2 (en) 2010-04-29 2013-04-16 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
WO2011137235A1 (en) 2010-04-29 2011-11-03 Cyberonics, Inc. Methods for detecting a seizure from cardiac data
US8649871B2 (en) 2010-04-29 2014-02-11 Cyberonics, Inc. Validity test adaptive constraint modification for cardiac data used for detection of state changes
US9566441B2 (en) 2010-04-30 2017-02-14 Medtronic, Inc. Detecting posture sensor signal shift or drift in medical devices
US8788045B2 (en) 2010-06-08 2014-07-22 Bluewind Medical Ltd. Tibial nerve stimulation
US8825164B2 (en) 2010-06-11 2014-09-02 Enteromedics Inc. Neural modulation devices and methods
US8679009B2 (en) 2010-06-15 2014-03-25 Flint Hills Scientific, Llc Systems approach to comorbidity assessment
US8641646B2 (en) 2010-07-30 2014-02-04 Cyberonics, Inc. Seizure detection using coordinate data
US9211411B2 (en) * 2010-08-26 2015-12-15 Medtronic, Inc. Therapy for rapid eye movement behavior disorder (RBD)
WO2012030831A1 (en) 2010-08-30 2012-03-08 Advanced Neuromodulation Systems, Inc. Use of a new stimulation design to treat neurological disorder
US8571643B2 (en) 2010-09-16 2013-10-29 Flint Hills Scientific, Llc Detecting or validating a detection of a state change from a template of heart rate derivative shape or heart beat wave complex
US8382667B2 (en) 2010-10-01 2013-02-26 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8337404B2 (en) 2010-10-01 2012-12-25 Flint Hills Scientific, Llc Detecting, quantifying, and/or classifying seizures using multimodal data
US8684921B2 (en) 2010-10-01 2014-04-01 Flint Hills Scientific Llc Detecting, assessing and managing epilepsy using a multi-variate, metric-based classification analysis
US8844537B1 (en) 2010-10-13 2014-09-30 Michael T. Abramson System and method for alleviating sleep apnea
US9457186B2 (en) 2010-11-15 2016-10-04 Bluewind Medical Ltd. Bilateral feedback
US9186504B2 (en) 2010-11-15 2015-11-17 Rainbow Medical Ltd Sleep apnea treatment
WO2012075198A2 (en) 2010-11-30 2012-06-07 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8577459B2 (en) 2011-01-28 2013-11-05 Cyberonics, Inc. System and method for estimating battery capacity
US9205262B2 (en) 2011-05-12 2015-12-08 Cyberonics, Inc. Devices and methods for sleep apnea treatment
US8855771B2 (en) 2011-01-28 2014-10-07 Cyberonics, Inc. Screening devices and methods for obstructive sleep apnea therapy
US9913982B2 (en) 2011-01-28 2018-03-13 Cyberonics, Inc. Obstructive sleep apnea treatment devices, systems and methods
US8562523B2 (en) 2011-03-04 2013-10-22 Flint Hills Scientific, Llc Detecting, assessing and managing extreme epileptic events
US9504390B2 (en) 2011-03-04 2016-11-29 Globalfoundries Inc. Detecting, assessing and managing a risk of death in epilepsy
US8562524B2 (en) 2011-03-04 2013-10-22 Flint Hills Scientific, Llc Detecting, assessing and managing a risk of death in epilepsy
US8761884B2 (en) 2011-04-14 2014-06-24 Cyberonics, Inc. Device longevity prediction for a device having variable energy consumption
US8725239B2 (en) 2011-04-25 2014-05-13 Cyberonics, Inc. Identifying seizures using heart rate decrease
US8761885B2 (en) 2011-04-29 2014-06-24 Cyberonics, Inc. Battery life estimation based on voltage depletion rate
US9402550B2 (en) 2011-04-29 2016-08-02 Cybertronics, Inc. Dynamic heart rate threshold for neurological event detection
EP2707094B1 (en) 2011-05-09 2016-02-03 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9192326B2 (en) 2011-07-13 2015-11-24 Dp Technologies, Inc. Sleep monitoring system
WO2013028960A1 (en) * 2011-08-25 2013-02-28 Insomnisolv, Llc System and method for the treatment of insomnia
WO2013036880A1 (en) 2011-09-08 2013-03-14 Thacker James R Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
US8983611B2 (en) 2011-09-27 2015-03-17 Cardiac Pacemakers, Inc. Neural control of central sleep apnea
CN104066476A (en) * 2011-09-30 2014-09-24 尼科索亚股份有限公司 Apparatus and method to control an implant
US9459597B2 (en) 2012-03-06 2016-10-04 DPTechnologies, Inc. Method and apparatus to provide an improved sleep experience by selecting an optimal next sleep state for a user
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
US8880192B2 (en) 2012-04-02 2014-11-04 Bio Control Medical (B.C.M.) Ltd. Electrode cuffs
US8676331B2 (en) 2012-04-02 2014-03-18 Nevro Corporation Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US9907959B2 (en) 2012-04-12 2018-03-06 Medtronic, Inc. Velocity detection for posture-responsive therapy
US9463317B2 (en) 2012-04-19 2016-10-11 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US9681836B2 (en) 2012-04-23 2017-06-20 Cyberonics, Inc. Methods, systems and apparatuses for detecting seizure and non-seizure states
US9737719B2 (en) 2012-04-26 2017-08-22 Medtronic, Inc. Adjustment of therapy based on acceleration
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US20140067021A1 (en) * 2012-08-28 2014-03-06 Ohio State Innovation Foundation Devices, systems, and methods for treating circadian rhythm disorders
WO2014087337A1 (en) 2012-12-06 2014-06-12 Bluewind Medical Ltd. Delivery of implantable neurostimulators
US9474876B1 (en) 2012-12-14 2016-10-25 DPTechnologies, Inc. Sleep aid efficacy
US9435830B2 (en) 2013-01-18 2016-09-06 Cyberonics, Inc. Implantable medical device depth estimation
US9731133B1 (en) 2013-01-22 2017-08-15 Nevro Corp. Systems and methods for systematically testing a plurality of therapy programs in patient therapy devices
US9610444B2 (en) 2013-03-15 2017-04-04 Pacesetter, Inc. Erythropoeitin production by electrical stimulation
US9056195B2 (en) * 2013-03-15 2015-06-16 Cyberonics, Inc. Optimization of cranial nerve stimulation to treat seizure disorderse during sleep
US9370660B2 (en) 2013-03-29 2016-06-21 Rainbow Medical Ltd. Independently-controlled bidirectional nerve stimulation
US9594354B1 (en) 2013-04-19 2017-03-14 Dp Technologies, Inc. Smart watch extended system
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US9395792B1 (en) 2013-06-14 2016-07-19 Dp Technologies, Inc. System including a sleep detection mechanism
US9241673B2 (en) 2013-09-30 2016-01-26 Cyberonics, Inc. Systems and methods for validating monitoring device placement and locations
US9675796B2 (en) 2013-11-10 2017-06-13 Brainsgate Ltd. Implant and delivery system for neural stimulator
US9302109B2 (en) * 2014-04-25 2016-04-05 Cyberonics, Inc. Cranial nerve stimulation to treat depression during sleep
US9585611B2 (en) 2014-04-25 2017-03-07 Cyberonics, Inc. Detecting seizures based on heartbeat data
WO2016073620A1 (en) 2014-11-06 2016-05-12 Maven Machines, Inc. System for monitoring vehicle operator compliance with safe operating conditions
US9597521B2 (en) 2015-01-21 2017-03-21 Bluewind Medical Ltd. Transmitting coils for neurostimulation
US9764146B2 (en) 2015-01-21 2017-09-19 Bluewind Medical Ltd. Extracorporeal implant controllers
US9517344B1 (en) 2015-03-13 2016-12-13 Nevro Corporation Systems and methods for selecting low-power, effective signal delivery parameters for an implanted pulse generator
US9782589B2 (en) 2015-06-10 2017-10-10 Bluewind Medical Ltd. Implantable electrostimulator for improving blood flow
US9713707B2 (en) 2015-11-12 2017-07-25 Bluewind Medical Ltd. Inhibition of implant migration
US20180056083A1 (en) * 2016-08-27 2018-03-01 Kosivana Holdings Limited Rtms pulse frequency optimization

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831181A (en) * 1956-01-27 1958-04-15 Warner Harold Respiration monitoring device
US3363242A (en) * 1965-04-07 1968-01-09 George W. Currey Eyelid actuated sleep warning system
US3584618A (en) * 1969-03-17 1971-06-15 Beckman Instruments Inc A system and method for monitoring a progressive sequence of physiological conditions
JPS5018714B1 (en) * 1970-12-29 1975-07-01
US3955562A (en) * 1975-05-19 1976-05-11 Farrar Jr Edward L Apparatus for measuring range of motion
US4580575A (en) * 1982-06-14 1986-04-08 Aequitron Medical, Inc. Apnea monitoring system
US5025807A (en) * 1983-09-14 1991-06-25 Jacob Zabara Neurocybernetic prosthesis
US4715367A (en) * 1986-09-15 1987-12-29 Crossley Robert B Multifunctional behavioral modification device for snoring, bruxism, and apnea
US4830008A (en) * 1987-04-24 1989-05-16 Meer Jeffrey A Method and system for treatment of sleep apnea

Also Published As

Publication number Publication date Type
EP0584211A1 (en) 1994-03-02 application
EP0584211A4 (en) 1995-11-15 application
WO1992019318A1 (en) 1992-11-12 application
US5335657A (en) 1994-08-09 grant

Similar Documents

Publication Publication Date Title
US5342409A (en) Position-responsive neuro stimulator
US6466822B1 (en) Multimodal neurostimulator and process of using it
US7025730B2 (en) System and method for automatically monitoring and delivering therapy for sleep-related disordered breathing
US6374140B1 (en) Method and apparatus for treating seizure disorders by stimulating the olfactory senses
US6104955A (en) Method and apparatus for electrical stimulation of the gastrointestinal tract
US7590455B2 (en) Controlling therapy based on sleep quality
US5354320A (en) Neurostimulator for production of periodic stimulation pulses
US6341236B1 (en) Vagal nerve stimulation techniques for treatment of epileptic seizures
US6662052B1 (en) Method and system for neuromodulation therapy using external stimulator with wireless communication capabilites
US20070161919A1 (en) Methods and systems for continuous EEG monitoring
US20050137645A1 (en) Novel method for the adjustment of human and animal vagus nerve stimulation
US20060122660A1 (en) Method and system for modulating sacral nerves and/or its branches in a patient to provide therapy for urological disorders and/or fecal incontinence, using rectangular and/or complex electrical pulses
US20060264777A1 (en) Event-based lead impedance monitoring
US20030074032A1 (en) Neural stimulation system and method responsive to collateral neural activity
US7717848B2 (en) Collecting sleep quality information via a medical device
US6529774B1 (en) Extradural leads, neurostimulator assemblies, and processes of using them for somatosensory and brain stimulation
US7801603B2 (en) Method and apparatus for optimizing vagal nerve stimulation using laryngeal activity
US20070027496A1 (en) Stimulating cranial nerve to treat pulmonary disorder
US20060235484A1 (en) Stimulation of a stimulation site within the neck or head
US20070025608A1 (en) Enhancing intrinsic neural activity using a medical device to treat a patient
US6351672B1 (en) System and method for modulating the pacing rate based on patient activity and position
US7974696B1 (en) Closed-loop autonomic neuromodulation for optimal control of neurological and metabolic disease
US20060009815A1 (en) Method and system to provide therapy or alleviate symptoms of involuntary movement disorders by providing complex and/or rectangular electrical pulses to vagus nerve(s)
US20070073355A1 (en) Apparatus and method for closed-loop intracranial stimulation for optimal control of neurological disease
US6366814B1 (en) External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders

Legal Events

Date Code Title Description
FZDE Dead